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1.1.1 Risk assessment of chemicals 
Manufactured chemicals are widely used in our society for multiple purposes, 
such as medical treatment, crop protection and house cleaning. The 
manufacturing, transfer and use of these products result in the release of 
thousands of xenobiotics into the environment. After emission, chemicals are 
transported and distributed across air, water, soil and sediment, where they 
may be degraded into transformation products by biotic or abiotic processes 
[1]. These xenobiotics and their transformation products can be taken up by 
aquatic and terrestrial organisms via different exposure routes, such as 
inhalation, absorption and food intake. The concentration of chemicals in 
organisms can be reduced through elimination processes, such as exhalation 
and egestion, or via biotransformation reactions mediated by enzymes. 
Chemicals can eventually accumulate in organisms if their uptake rate is faster 
than their elimination rate from the organism. It is important to determine to 
what degree chemicals accumulate, since xenobiotics that enter the body may 
exert hazardous effects on humans and animals. 
Regulators have taken measures to improve the protection of organisms and 
ecosystems against the risks that can be posed by exposure to chemicals. For 
example, the European Union (EU) adopted the REACH (Registration, 
Evaluation, Authorization and restriction of CHemicals) legislation, which 
entered into force on 1 June 2007 [2]. The REACH regulation makes companies 
responsible to ensure that the substances they manufacture and market in the 
EU can be used safely. Registrants must provide data on physicochemical and 
(eco)toxicological properties of substances, following clearly defined 
information requirements that are tonnage and risk related [3]. These data 
have to be used to assess the risks arising from the entire chemical life cycle, as 
well as to develop and recommend appropriate risk management measures to 
control these risks. The information gathered and the assessment performed 
must be submitted to the European Chemicals Agency (ECHA) to be evaluated 
for the registration [4]. 
The data needed for the risk assessment of chemicals include toxicological and 
(eco)toxicological endpoints such as skin irritation, mutagenicity, terrestrial 
and aquatic toxicity, bioaccumulation, etc. These data are conventionally 
measured in laboratory experiments. Due to ethical, financial and practical 
constraints, not all chemicals can be tested on all species [5]. Thus, REACH 
promotes alternative methods to replace, reduce and refine the use of animals 
in scientific procedures (3Rs principle), provided that the use of reliable 
alternative methods is justified with a scientific explanation. Alternative 
estimation methods include in vitro experiments [6] and in silico models [7]. 
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1.1.2 Quantitative Structure Activity Relationship 
Quantitative Structure Activity Relationships (QSARs) represent a widely used 
in silico modelling approach for estimating the biological activity of a substance 
from features of its chemical structure. The fundamental assumption of QSARs 
is that the structure of a chemical implicitly determines its physicochemical 
properties, which, in interaction with a biological system, determine its 
(eco)toxicological properties [8]. QSAR modelling generally involves three 
steps: 1) collection of experimental data measuring the property or biological 
activity of interest (endpoint) for different chemicals; 2) calculation of 
descriptors that represent properties and/or features of the molecular 
structure of the chemicals; 3) application of statistical methods that relate 
descriptors to the endpoint. One of the most common and transparent 
methods is Multiple Linear Regression (MLR), where the endpoint is expressed 
as a linear function of a limited number of descriptors [9]. The development of 
QSARs has two main practical purposes. First, it provides insights into 
mechanisms of biological processes and allows for the identification of 
important structural characteristics and/or physicochemical properties 
influencing the endpoint. Second, it allows for the prediction of the biological 
activity of untested chemicals from their structures, thus contributing to the 
3Rs in the risk assessment of chemicals [10]. 
The appropriate descriptors to model a defined endpoint can be chosen with 
two main approaches, depending on the aim of the QSAR. In the “mechanistic” 
approach, chemical structure is represented only by few molecular descriptors 
of clear physicochemical interpretation, related to the size, chemical reactivity 
and partitioning of the substances. For example, the octanol-water partition 
coefficient (Kow) has often been related to many different endpoints, e.g. soil 
sorption, bioaccumulation and baseline toxicity [11], as it approximates the 
ability of a chemical to reach the site of action. The Kow is defined as the ratio 
of the concentration of a chemical in n-octanol and water at equilibrium and 
represents the hydrophobicity (or lipophilicity) of a compound. The 
“mechanistic” descriptors are chosen by the modeller on the basis of a priori 
knowledge of the mechanism of the endpoint [12], with the aim to enhance 
understanding and provide a more rational basis for risk assessment. 
Alternatively, in the “statistical” approach, chemical structure is represented 
by a large number (usually thousands) of theoretical molecular descriptors, 
such as topological and fragment based indices, which encode multiple aspects 
of the molecular structure. The “theoretical” descriptors for the QSAR are then 
selected by different chemometric methods as the best correlated with the 
endpoint, with the main aim to optimise model performance for prediction 
[12]. 
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1.2 Biotransformation of chemicals 
1.2.1 The role of biotransformation in bioaccumulation modelling 
In bioaccumulation modelling, biotransformation is one of the processes that 
decrease the concentration of metabolisable compounds in an organism, 
together with elimination through other physiological processes, such as 
exhalation and egestion. Through biotransformation, the parent compound is 
converted via enzymatic reactions into another chemical (metabolite), which is 
usually more soluble and thus can be excreted more easily. There are two 
types of biotransformation reactions: Phase 1 (hydrolysis, reduction and 
oxidation) and Phase 2 (conjugation) reactions [13]. During Phase 1 reactions, 
the parent compound is transformed by introducing polar functional groups 
(such as -OH, -COOH or -NH2). Phase 2 reactions combine the substrate (a 
parent compound or more commonly a Phase 1 metabolite) with an 
endogenous substance (such as glutathione, glucuronide or acetic acid). To be 
metabolised, the chemical must reach the enzyme and bind to it; then, a 
catalytic reaction must occur. Therefore, the biotransformation rate (km, d
-1) is 
determined both by the internal distribution and the capacity of the enzyme to 
bind and transform the substrate [1]. 
Models have been developed to assess the bioaccumulation of chemicals by 
quantifying the kinetic rate constants of uptake and elimination (mass balance 
models) [14, 15]. Rates of elimination via exhalation with air, excretion with 
urine and egestion of non-digested food can be predicted quite accurately 
from properties of chemical substances and biological species, such as 
chemical Log Kow and organism size [15, 16]. On the contrary, 
biotransformation rates (km, d
-1) are difficult to estimate because they apply to 
a specific combination of a chemical and enzymes and vary among individual 
organisms and species. In fact, multiple enzyme systems exist and the overall 
metabolic rate depends on the enzyme composition, i.e. concentration and 
activity. Because of the lack of information regarding biotransformation 
capabilities, km values were often not considered in the determination of 
bioaccumulation of chemicals, leading to overestimation of the 
bioaccumulation for metabolisable chemicals [16]. Biotransformation was in 
fact shown to largely influence bioaccumulation of metabolisable chemicals in 
both mammals and fish [17, 18]. 
1.2.2 Quantification of biotransformation 
Limited km data measured for the whole-body in vivo are available in the 
scientific literature, since it is difficult to isolate metabolism from the plethora 
of other physiological processes [19, 20]. Because of the important 
contribution of biotransformation to the bioaccumulation of chemicals, many 
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efforts have recently been made to obtain km values following generally two 
approaches: 1) from measured total elimination rates using (mechanistic) 
mass-balance models; 2) by extrapolating in vitro measurements of the 
metabolic constants to their whole-body in vivo equivalents, as explained in 
Chapter 7. In the first approach, the biotransformation rate of organic 
chemicals can be estimated for various species groups as the difference 
between measured elimination rate constants and the sum of elimination rate 
constants predicted assuming no metabolism [20]. For humans, 
biotransformation rates have recently been estimated from measured total 
elimination rates with a mass balance model [21] and subsequently used to 
develop QSARs. In the second approach, the biotransformation potential is 
commonly assayed via the measurement of intrinsic clearance (CLINT, mL min
-1 
kgBW
-1) in in vitro systems derived from liver tissue, such as isolated 
hepatocytes, microsomes, S9 fractions or isolated enzymes. Liver is in fact the 
principal organ responsible for the metabolism in fish and mammals [1, 22]. 
The in vitro CLINT is calculated as the ratio between the maximum reaction rate 
(Vmax) and the Michaelis-Menten constant (Km). The hepatic CLINT is then 
incorporated into established physiologically based models for the estimation 
of km values [19]. A stepwise approach for in vitro to in vivo extrapolation 
(ivive) was initially developed for mammals by the pharmaceutical industry to 
support preclinical screening of drug candidates [23]. 
1.2.3 Kinetics of biotransformation 
Understanding enzyme kinetics is important to determine the metabolic rate 
and to obtain a better mechanistic understanding of biotransformation 
reactions [1]. Enzymes are proteins and their catalytic function occurs within a 
pocket named active site. The surface of the enzyme active site is lined with 
functional groups (amino acid side chains, inorganic metal ions or coenzymes) 
that bind the substrate and then catalyse its chemical transformation into a 
product, leaving the enzyme chemically unchanged [24]. When the substrate 
reaches the enzyme, the functional groups on the active site sequester the 
chemical from aquatic solution, forming a transient enzyme-substrate complex 
via weak non-covalent interactions (hydrogen bonds, hydrophobic and ionic 
interactions). The weak binding interactions between enzyme and substrate 
contribute to its successive catalysis, as they hold the substrate and bring 
specific functional groups into the optimal position to react. In the catalytic 
step, the cleavage and formation of covalent or ionic bonds between the 
substrate and the catalytic functional groups result in the release of the 
product and the return of the enzyme to its original state. 










E + P      (Eq. 1.1) 
where E, S and P represent the enzyme, substrate and product; ES is the 
enzyme-substrate complex; and k1, k-1, k2, k-2 (d
-1) are the rate constants for 
formation and breakdown of ES. Early in the reaction, product concentration 
[P] is negligible, thus the reverse reaction PES described by k-2 is assumed to 







⇀ E + P      (Eq. 1.2) 
where kcat (d
-1) is the rate constant for P formation, which is usually the rate 
limiting step in the overall enzymatic reaction [24]. The rate constant kcat is also 
named turnover number and represents the amount of S converted to P per 
time unit on a single enzyme molecule. The initial reaction rate (V0, mol min
-1 
mgE
-1) is defined as the amount of P formed per time unit per amount of 
enzyme. For many enzymes, V0 varies with substrate concentration ([S], mol L
-
1) following the typical Michaelis-Menten plot shown in Figure 1.1, assuming 
the total enzyme concentration [ET] to be constant and considerably smaller 
than [S]. 
 
Figure 1.1. Effect of substrate concentration [S] on the initial rate of an 
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At lower [S], V0 increases linearly with substrate concentration. At higher [S], 
V0 begins to level off until it approaches a maximum and the reaction is 




       (Eq. 1.3) 
Where Vmax (mol min
-1 mgE
-1) is the maximum reaction rate and Km (mol L
-1) is 
the substrate concentration at half Vmax. The catalytic step of the enzymatic 
reaction is described by Vmax, which is equal to the product between kcat and 
[ET]. The Michaelis-Menten constant Km is independent of [ET] and typically 
describes the binding step [25]. If the catalytic step is slow compared with the 
dissociation of S from E (kcat<<k-1), Km reduces to k-1/k1, which is defined as the 
dissociation constant Kd of the ES complex. In this case, the inverse of Km 
reflects the affinity of the enzyme for its substrate: a high 1/Km (or low Km) 
corresponds to high binding affinity [24]. 
 
1.3 Problem setting 
In environmental modelling, the prediction of the biotransformation rate is a 
difficult task due to the specific action of metabolism, which depends on the 
chemical and the enzyme involved and varies among individual organisms and 
species. Enzymes determine the qualitative and quantitative aspects of 
biotransformation [1], thus investigations on the mechanisms governing 
metabolism should start from the enzyme level. 
QSARs have been built to estimate the enzymatic constants (Km and Vmax) for 
drugs oxidised by cytochrome P450 (CYP) in mammals [26, 27]. These 
constants were correlated with mechanistic descriptors representing easily 
interpretable physicochemical properties of substrates. The binding affinity, 
represented by 1/Km, was mainly correlated with compound hydrophobicity, 
expressed as Log Kow [25, 28], probably because of desolvation effects. The 
maximum rate Vmax was mostly influenced by electronic properties, such as 
frontier orbital energies or hydrogen bonding [29-31]. In fact, catalytic 
processes are characterised by cleavage and formation of covalent bonds [25]. 
However, the above-mentioned studies considered only a limited series of 
P450 substrates, mainly drugs. CYP is the major (and thus the most studied) 
enzyme group in terms of catalytic versatility and the large number of 
xenobiotics it detoxifies or activates [13]. Nevertheless, the contribution of 
other enzymes to the oxidative metabolism of xenobiotics is significant as well 
[32]. Despite their importance, QSARs for non-CYP enzymes have hardly been 
developed. In addition, the above mentioned studies only used mechanistic 
descriptors. Given the complexity of the underlying metabolic reactions, 
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theoretical molecular descriptors (such as topological indices and functional 
group counts) might be more appropriate to identify the chemical features 
influencing metabolism of large sets of diverse chemicals. 
In order to quantify biotransformation rates, it is necessary to obtain Km and 
Vmax values measured in in vitro systems derived from liver tissue (e.g. isolated 
hepatocytes, microsomes), which have to be extrapolated to their whole-body 
in vivo equivalents. Measurements of Km and Vmax values from liver tissue are 
lacking for many chemicals and species. A few models have been built to 
predict in vitro clearance for mammals (measured mainly in microsomes or 
hepatocytes) using information on the chemical structure [33-36], but these 
models included only pharmaceuticals. Although data are available, no QSARs 
have been developed yet to predict in vitro CLINT including environmental 
pollutants. In addition, the ivive methods developed for mammals were used 
mainly for drugs, with the aim to accelerate the selection of new candidates in 
the drug discovery stage based on their predicted clearance. Despite the 
importance of biotransformation for the risk assessment of environmental 
pollutants, few attempts have been made to derive km values from ivive 
methods. 
 
1.4 Aims and outline 
The overall aim of this thesis is to develop QSARs for the prediction of 
biotransformation of xenobiotics in mammals based on their chemical 
properties. 
Compared with previous QSARs for biotransformation that were available only 
for drugs, the focus of this thesis is on both pharmaceuticals and 
environmental pollutants metabolised in mammals. In addition, the 
relationships between metabolic activity and chemical structure were 
developed using different types of descriptors, first Kow only, then mechanistic 
descriptors and finally theoretical descriptors. Moreover, QSARs were 
developed for systems representing different levels of biological organization 
(isolated enzymes, hepatocytes and microsomes). In Figure 1.2 a schematic 
overview is given of the thesis content. 
The general mechanisms underlying metabolism were investigated starting 
from the enzyme level. The focus was on the liver metabolism in mammals 
mediated by four important oxidising enzymes: ADH, ALDH, FMO and CYP. 
First, the influence of compound hydrophobicity (Log Kow) on metabolism was 
investigated. In Chapter 2, the change in Log Kow of the parent compound after 
it is metabolised was quantified. In Chapter 3, the relationships between Log 
Kow and the Km values measured in purified enzymes were investigated. Next, 
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the relationships between the metabolic constants (Km and Vmax measured in 
purified enzymes) and chemical properties were analysed. QSARs were 
developed using mechanistic descriptors known to influence metabolism 
(Chapter 4), as well as theoretical descriptors (Chapter 5). 
Successively, Km and Vmax values were also collected for whole liver cells and 
sub-cellular fractions (hepatocytes and microsomes) to build QSARs predicting 
clearance, i.e. Vmax/Km (Chapter 6). These models were interpreted also in the 
light of the results found for enzymes. 
Finally, in Chapter 7 the advantages and disadvantages of the different types of 
descriptors and levels of biological organization are discussed. A general 
scheme was developed to perform in vitro-in vivo extrapolations (ivive). This 
scheme was used to derive km values using clearance collected for human 
microsomes and hepatocytes. The extrapolated km values were compared to in 
vivo measurements in order to validate the ivive method. Finally, a tentative 
refinement of the accumulation of the parent compound based on the change 
in hydrophobicity after metabolism is discussed. 
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Risk assessment of xenobiotics present in the environment needs 
comprehensive evaluation of accumulation potential in organisms. Recently 
developed in silico mechanistic models estimate the bioaccumulation factors 
of chemicals, calculated as the difference between uptake and elimination 
rates from organisms [15]. In addition to the excretion via urine, egestion via 
feces and growth dilution, labile compounds can be eliminated by metabolism. 
Yet, prediction of biotransformation rates is difficult [20]. 
The importance of biotransformation in drug activity [37] and in assessing 
human risk of environmental toxicants [38] has led to a growing interest in the 
metabolic pathways of chemicals in bacteria, fish, mammals and other species 
[39-44]. Quantitative Structure-Activity Relationships (QSARs) have been 
developed to predict metabolic rates of drugs as well as environmental 
pollutants, like pesticides and PAHs. Metabolic rates have also been estimated 
as the difference between the predicted elimination rate neglecting 
biotransformation and the observed experimental value [20]. 
However, up to date no direct comparison has been made between the 
physicochemical properties of xenobiotics and their metabolites. Yet, such 
comparisons could shed light on general patterns of metabolism. The objective 
of the present study was to estimate the difference in lipophilicity, expressed 
by the octanol-water partition coefficient (Kow), between parent compounds 
and their metabolites for a number of organic pollutants. Parent compounds 
are usually transformed by enzymes into more polar metabolites to be 
excreted more rapidly; the present work quantifies this difference. The 
approach can also be considered as a first indication of increased elimination 
to be used in exposure and risk assessment if empirical data and refined 
models are lacking. 
 
2.2 Materials and methods 
2.2.1 Theory 
The octanol-water partition coefficient (Kow) is often used in risk assessment to 
predict intake, accumulation and excretion rates of chemicals [15]. Elimination 
rate constants for persistent chemicals generally decrease with the Kow (Figure 
2.1) [45, 46]. Biotransformation usually reduces the lipophilicity of the 
compound, facilitating its excretion via aqueous fluids [47]. If the parent 
compound is immediately and totally metabolised, it can be assumed that the 
elimination of the metabolite is similar to that of a persistent compound which 
is as lipophilic as the metabolite. As an example, Figure 2.1 shows the increase 
of the elimination rate constant by a factor of 10, from about 0.08 to 0.80, as a 
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result of the reduction of the Kow by two orders of magnitude, i.e. from 10
5 to 
103. The dashed line refers to elimination rate constants representing total 
physical-chemical elimination of persistent compounds, i.e. without 
biotransformation, in 10-1 kg mammals [15]. 
 
Figure 2.1. Effect of a Kow reduction from parent compound (PC) to metabolite 
(M) on the elimination rate constant. Background graph taken from Hendriks 
et al. 2001 [15]. 
 
2.2.2 Data collection 
Information on the metabolic pathways of a set of environmental pollutants 
(parent compounds) was taken from the scientific literature and from two 
publicly available databases: Hazardous Substances Data Bank (HSDB, 
http://toxnet.nlm.nih.gov/) and Toxin and Toxin Target Database (T3DB, 
http://www.t3db.org/). We built a database including those pollutants that 
have one main metabolic pathway in mammals and that are oxidised by the 
enzymes alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH) and 
cytochrome P450 (P450) [48]. The parent compounds were grouped according 
to their first “metabolite”, i.e. to the reaction they undergo. We considered the 
following biotransformation reactions: alcohol oxidation (by ADH), aldehyde 
oxidation (by ALDH) and the more common types of P450 reactions [49, 50], 
i.e. hydroxylation, dihydroxylation, epoxidation and heteroatom (N, S) 
oxygenation. Appendix A provides a scheme with the biotransformation 







































relative metabolites can be also found in Appendix A (Table A2), together with 
their Log Kow values and literature references. 
The octanol-water partition coefficients of parent compounds and metabolites 
were taken from the ChemSpider database (freely accessible at 
http://www.chemspider.com/). ChemSpider reports the experimental Log Kow 
values (when available in the database), as well as the predicted values 
calculated by the ACD/logP program [51], without the relative uncertainties. 
This program has the advantage of accounting for the positional (topological) 
effect of substituents on a chemical structure [52]. 
2.2.3 Data treatment 
The Log-transformed octanol-water partition coefficients of the metabolites, 
Log Kow (metabolite) were related to the parent compounds, Log Kow (parent), 
according to 
Log Kow (metabolite) = a∙Log Kow (parent) + b (Equation 1). 
The linear parameters a (slope) and b (intercept), as well as the statistical 
standard error (SE), the correlation coefficient (r2), 95% the confidence interval 
(95%CI), and the significance level (p) were determined. Slopes and intercepts 
were analysed for significant deviation from a=1 and b=0, respectively, i.e. 
from the bisector representing a 1:1 relation between the Log Kow values of 
parent compounds and metabolites. 
We developed one regression per enzyme (general regressions) and one per 
biotransformation reaction. A first set of regressions was built using Log Kow 
values calculated by the ACD/logP program and a second one using 
experimental Log Kow values, when available for at least 5 parent compounds 
and their relative metabolites. An analysis of covariance (ANCOVA) [53] was 
performed to compare the regressions with experimental Log Kow values with 
the regression with predicted values. If the pancova resulting from the test for 
homogeneity of regression was lower than 0.05, we considered the two 
regressions significantly different from each other. 
 
2.3 Results 
In Figure 2.2, the Log Kow of the parent compound is plotted against the Log Kow 
of the metabolite, using calculated (empty symbols, thin lines) and 
experimental values (full symbols, thick lines). Tables 2.1 and 2.2 provide the 
regression equations and statistical parameters obtained for all metabolic 
pathways considered, using calculated and experimental Log Kow values, 
respectively. All regressions were significant at the 0.01 level (p<0.01). 
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The regressions with predicted Log Kow had high correlation coefficients: r
2 was 
higher than 0.85, except for dihydroxylation (r2=0.71) and N-hydroxylation 
(r2=0.63). The slopes were equal to 1 within a 95% CI. The general regression 
lines (Figure 2.2) gathered around the intercepts b=0 (ADH and ALDH) and b=-1 
(CYP), indicating metabolic pathways that do not change the Kow of substrates 
and metabolic pathways that lower the Kow by a factor of 10, respectively. 
More in detail (Table 2.1), for hydroxylation and epoxidation the intercept was 
statistically similar to -1 within a 95% CI, while for dihydroxylation and 
sulphoxidation it was around -2. In contrast, the intercepts were about 0 for N-
hydroxylation and for the oxidation of alcohols to aldehydes and to ketones. 
Using experimental Log Kow data, we also set up nine validation regressions 
(Table 2.2 and thick lines in Figure 2.2). These regressions were significant at 
the 0.01 level, with explained variance ranging from 70 to 99%. The regressions 
with experimental and with predicted Kow values were statistically similar, with 
the exception of aromatic hydroxylation and the regressions mediated by ADH, 
which had pancova<0.05. 
 
Figure 2.2. Log Kow values of metabolites versus parent compounds, using 
predicted (empty dots) or experimental (full dots) Log Kow values, for the 
following biotransformation reactions: a. hydroxylation; b. epoxidation; c. 
dihydroxylation; d. sulphoxidation; e. N-hydroxylation; f. oxidation of alcohols 
to aldehydes; g. oxidation of alcohols to ketones; h. oxidation of aldehydes. 
Dashed lines indicate the 1:1 bisector (a=1 and b=0), while solid lines indicate 
the regressions with predicted (thin lines) or experimental (thick lines) Log Kow 
values. 
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2.4 Discussion 
2.4.1 Calculation methodology 
In this study, we related the Log Kow of parent compounds to the Log Kow of 
their first metabolites in mammals, dividing the data according to the 
metabolic pathway. We also built general regressions merging data per 
enzyme group (CYP, ADH, ALDH). 
All regressions developed with predicted Log Kow values were robust and 
statistically significant and had slopes containing the value of 1 in their 95% 
confidence intervals (Table 2.1). The dispersion of the data in Figure 2.2 (empty 
symbols, thin lines) was generally similar both at low and high Kow, indicating 
that the total lipophilicity depends on electronic interactions among 
substituents of the chemical structure. Errors and uncertainties affecting the 
calculated values of Kow were not provided by the Chemspider database. 
Nevertheless, as the same error affects both parent compounds and 
metabolites, the pattern still remains consistent. 
The interpretation of the results is closely related to the method used to 
calculate the Kow. Since the octanol-water partition coefficient has long been 
known as an “additive-constitutive” property [51], the ACD/logP software uses 
the basic approach of “group contribution”, which is valid among different 
chemical classes and in a large range of Log Kow values. If a metabolic process 
effectively “removes” a group of atoms and “inserts” a different one, the 
overall lipophilicity change will depend only on the difference between the 
contribution of both group. For this assumption, each regression is expected to 
have a slope of exactly one, as the difference is independent of the total 
lipophilicity of the molecule. In other words, Equation 1 can be considered in 
terms of a Hammett equation: Log(Kow(metabolite)/Kow(parent))=b. In this equation 
Kow coefficients are equilibrium constants which can be related to free energies 
of solvation by simple thermodynamical laws. Thus, the difference between 
Log Kow becomes the difference between free energies of solvation of the 
metabolite and parent compound. The intercept "b" is negative when 
Kow(metabolite)<Kow(parent) and positive when Kow(metabolite)>Kow(parent). In Hammett 
terms ("total electronic effect") this means that the insertion of an oxygen 
atom or link has a favouring or disfavouring electronic effect on the solvation 
by water. Usually, this insertion favours the water solubility for several 
reasons: raised molecular volume, raised H-bond basicity, raised polarizability, 
etc. Thus, the intercept "b" is expected to be negative for the oxidation 
reactions considered in our study. 
We set up 9 validation regressions using experimental Log Kow values and 
analysed their similarity to the regressions with predicted Log Kow. The pancova 
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resulting from the analysis of covariance (Table 2.2) confirmed the 
homogeneity between the two types of regressions, with the exceptions of 
aromatic hydroxylation and the regressions for ADH, with pancova<0.05. Figures 
2.2a and 2.2f show deviations for two data points: pyridine and methanol 
(experimental Log Kow values), undergoing aromatic hydroxylation and alcohol 
oxidation, respectively. It is interesting to note that formaldehyde presented a 
deviation in the regression for ALDH compounds with experimental Log Kow 
data (Figure 2.2h). Formaldehyde (CH2O) and methanol (CH3OH) are the 
simplest aldehyde and the simplest alcohol, respectively. Thus, these 
molecules may not adhere to general trends because of their small size. In 
order to test the sensitivity, regressions were developed removing pyridine, 
methanol and formaldehyde from their respective datasets with experimental 
Log Kow. The results are reported in Table 2.2: the fit was improved, as well as 
the homogeneity of the regressions (higher pancova). 
2.4.2 Intercepts 
The regression lines reflect an increase (intercept > 0) or decrease (intercept < 
0) of the lipophilicity after biotransformation. The oxidation reactions of 
alcohols and aldehydes did not lead to a significant lipophilicity change, having 
intercepts of about zero. While this may be at odds with the high metabolic 
rates usually noted for alcohols [48], one has to keep in mind that this 
hydrophobicity trend allows the reverse reduction of aldehydes to alcohols 
driven by the alcohol dehydrogenase [54]. Furthermore, the majority of acids 
deprotonate at cytosolic pH, the ionic form being more water-soluble, thus 
more easily excretable. 
The decrease in lipophilicity differed for the single reactions mediated by CYP 
enzymes. Hydroxylation and epoxidation reduced the lipophilicity by one order 
of magnitude (b=-0.97 and b=-1.04, respectively). Dihydroxylation and 
sulphoxidation reduced the Kow by two orders of magnitude (b=-1.97 and -2.02, 
respectively). The two orders of magnitude difference for sulphoxidation was 
confirmed by a similar study on the oxidation of alkyl sulphides [55]. 
Experimental Log Kow values of eight phenyl and biphenyl alkyl amines 
(tertiary) were a linear function of their N-oxidised metabolites in a neutral 
form, with r2=0.93 and p<0.01 [56]. Caron et al. concluded that the neutral N-
oxides had a Log Kow value lower than that of the parent amine by a factor 
ranging from 2.61 and 2.77. This decrease is higher than those observed with 
our correlations, due to the differences in chemical structure with respect to 
the chemicals in this study’s dataset. We analysed the N-oxygenation of 
primary and secondary amines to hydroxylamines, which is the only reaction 
mediated by CYP enzymes that cause no change in Log Kow, with the intercept 
close to zero. Overall, Log Kow was shown to be reduced by one unit for 
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chemicals that are typically metabolised by CYP, the intercept being -1.13. The 
biotransformation reactions considered in the present study are the more 
common reactions mediated by CYP enzymes. 
The excretion of stable compounds decreases with hydrophobicity [15]. Vice 
versa, a reduction of the Kow by biotransformation will thus enhance 
elimination to an extent that may be anticipated by the same relationship 
(Figure 2.1). Obviously, empirical confirmation by future studies is needed. As 
metabolism rates are hard to anticipate with existing methods, we feel that 




Comparisons of lipophilicity and preliminary discussions on their significance 
play a key role in understanding the natural logic of metabolism. The present 
study shows that the Log Kow is reduced by a factor that varies between 0 and -
2, depending on the metabolic pathway. The magnitude of the reduction can 
be anticipated by analysing the way the Kow is calculated. Knowing the 
magnitude of the reduction is a first necessary step in an alternative approach 
to estimating biotransformation rates.  
 
Appendix 
Appendix A provides a scheme with the biotransformation reactions on 
chemical moieties (Table A1). The parent compounds and the relative 
metabolites can be found in Table A2 of Appendix A, together with their Log 
Kow values and literature references. 
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The EU REACH (Registration, Evaluation, Authorization and restriction of 
CHemicals) legislation [2] requires the risk assessment of thousands of 
chemicals to evaluate the potential adverse effects that exposure to chemicals 
may have on human health and the environment. Due to financial, practical 
and ethical constraints, not all compounds can be tested on all species to be 
protected. Thus, models are needed to predict fate and effects of new and 
existing chemicals [7]. 
The accumulation of xenobiotics in organisms is a key factor in the risk 
assessment of chemicals. In bioaccumulation models, biotransformation is one 
of the processes decreasing the concentration of chemicals in an organism, 
together with elimination through physicochemical processes, e.g. excretion 
via water, egestion via faeces and growth dilution [15]. Parent compounds can 
be transformed via enzymatic reactions to metabolites, which are usually more 
polar and can thus be excreted more easily. The enzymatic action of 
metabolism involves two processes. Firstly, the chemical needs to reach the 
enzyme and bind to it; secondly, a catalytic reaction has to take place. The 
binding of the chemical and its successive catalysis are described by two 
enzymatic parameters: the Michaelis constant (Km) and the maximum rate of 
the reaction (Vmax), respectively [25]. The Km value is the substrate 
concentration at half the maximum rate, i.e. at Vmax/2, and is independent of 
the enzyme concentration [1]. The inverse of the Michaelis constant, i.e. 1/Km, 
reflects the affinity of the enzyme for its substrate: a low Km (or high 1/Km) 
corresponds to high binding affinity. 
Measured Km and Vmax data are lacking for many chemicals and species. Models 
based on experimental data can be used to predict the biological activity of a 
broader range of related chemicals. So far, QSARs have been developed to 
explore the relationships between the enzymatic constants (Km and Vmax) and 
substrate characteristics with regard to drugs oxidised by the microsomal 
cytochrome P450 (CYP) [26, 27]. The affinity, represented by 1/Km, was shown 
to be mainly related to the lipophilicity of the compound (see reviews [25, 28]), 
although other factors might also be important, such as ionic interactions and 
hydrogen bonding properties [30]. However, these models focussed on single 
CYP isoenzymes and small datasets, mainly drugs. We investigated the 
relationship between affinity and lipophilicity extending the analysis to a 
broader set of chemicals. CYP is the major (and thus the most studied) enzyme 
group in terms of catalytic versatility and the large number of xenobiotics it 
detoxifies or activates [13]. Nevertheless, the contribution of other enzymes to 
the oxidative metabolism of xenobiotics is significant as well [32]. Despite their 
importance, QSARs for non-CYP enzymes have not been developed. We 
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hypothesised that the lipophilicity-binding regressions found for small datasets 
of CYP substrates could be extended to non-CYP enzymes. 
The aim of this study was therefore to estimate the relationships between Km 
and lipophilicity, expressed by the octanol-water partitioning coefficient (Kow), 
in mammals. Regressions were developed for oxidations catalysed by alcohol 
dehydrogenase (ADH), aldehyde dehydrogenase (ALDH), flavin-containing 
monooxygenase (FMO) and CYP enzymes, in order to find generic patterns of 
metabolism across enzymes. 
 
3.2 Methods 
3.2.1 Data selection 
Michaelis constants (Km) were collected for alcohol dehydrogenase (ADH), 
aldehyde dehydrogenase (ALDH) and flavin-containing monooxygenase (FMO). 
For ADH and ALDH, data were taken from the BRENDA enzyme database 
(BRaunschweig ENzyme DAtabase, http://www.brenda-enzymes.org) [57]. Km 
values for FMO were taken from a review [58] and references contained 
therein. We also collected Km values for cytochrome P450 (CYP) from reviews 
[26, 59, 60]. All data extracted from the BRENDA database and the reviews 
were checked in the original papers. We assumed that Km data were of 
adequate quality as taken from peer reviewed articles. 
Michaelis constants (Km, reported in μM) were combined into four databases, 
one for each enzyme family. Inclusion criteria were as follows: Km measured for 
mammals in in vitro assays of purified, non-recombinant, hepatic enzymes. For 
every Km value, we recorded the species and the enzyme for which it was 
measured, and the experimental conditions such as pH and temperature. 
SMILES (Simplified Molecular Input Line Entry System) strings [61] and CAS 
(Chemical Abstract Service) numbers were obtained for each compound from 
the ChemSpider website (http://www.chemspider.com/). The octanol-water 
partitioning coefficients (Kow) were taken from the KOWWIN
TM v 1.67, a 
program of EPI Suite™ available at the website of US EPA (Environmental 
Protection Agency http://www.epa.gov). Experimental Kow values, when 
available, were preferred over estimated ones. As the datasets included a 
number of compounds that would be ionised at physiological pH (7.4), we 
obtained Log D7.4 values from ChemSpider, which are calculated using the 
software ACD Laboratories LogD (Advanced Chemistry Development 
ACD/Laboratories Research, Toronto, Canada). The distribution coefficient D7.4 
represents the partitioning coefficient corrected for ionisation of the chemical 





Each compound was assigned to relevant chemical classes using the ECOSARTM 
program v 1.0 present in EPI Suite™. ECOSAR recognises the presence of 
specific functional groups denoting the compound. If the functional group is 
detected then the compound is allocated into the respective class(es) [62]. 
The Km data collected can be found in Appendix B (Table B1), with the 
references to the original papers. 
3.2.2 Data treatment 
For each enzyme family, data were grouped per species (i.e. human, horse, rat, 
mouse, pig and rabbit) and isoenzymes. The isoenzymes are any of the several 
forms of an enzyme, all of which catalyse the same reaction but are 
characterised by varying properties (e.g. electrophoresis, chromatography, 
kinetics criteria, chemical structure, etc). Regressions were developed for each 
combination of a species and isoenzyme (specific regressions). In addition, all 
species and isoenzymes were merged into one regression per enzyme family 
(general regression). 
Each substrate was characterised by a single value in order to prevent bias due 
to the overrepresentation of Km values of substrates which were measured 
either in different species and/or isoenzymes, or more than one time in the 
same combination of species and isoenzyme. For this purpose, if multiple 
values were available for one substrate, we calculated the geometric mean of 
the experimental Km values, as well as the geometric standard deviation. 
3.2.3 Data analysis 
Linear regression analysis was performed using the Ordinary Least Squares 
(OLS) method. Among all datasets built with the different combinations of 
species/isoenzymes, we included in the analysis only those containing at least 
6 compounds. For each dataset, the QSAR equations were developed in the 
form: 
Log (1/Km) = a∙Log Kow + b     (Eq. 3.1) 
We reported the slope (a) and the intercept (b) with their standard errors. The 
quality of the regression was characterised by the number of compounds used 
in the model (n), coefficient of determination (r2), standard error for the 
estimated parameter Log (1/Km) (SE) and the p-value from the F-test (p). We 
also calculated the 95% Confidence Interval (95%CI) for slopes and intercepts. 
In order to explore the influence of ionisation in enzyme binding, we also 
developed the general regressions for the four enzyme families using Log D7.4 
values instead of Log Kow. 
An analysis of covariance (ANCOVA) was performed to compare every specific 
regression with the general regression, within an enzyme group. If the 
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resulting pancova was lower than 0.05, we considered that the two regressions 
significantly differ from each other. 
In addition, separate regressions were developed for specific groupings of 
compounds metabolised by FMO and CYP for which we expected a similar 
behaviour. The FMO database contains several chemicals that are used as 
pesticides and are biologically highly active: 12 organophosphorous (OP), 4 
carbamate (CM) and 5 dithiocarbamate (DTC) compounds. A list of these 
compounds is reported in Appendix C (Table C1), together with their original 
ECOSAR classes and their general structure. The ECOSAR software does not 
separately categorise reactive chemicals such as OPs and CMs [63]. Therefore, 
we manually classified them and made a separate regression for OP pesticides, 
the only group with more than 6 compounds. For CYP, which has a wide 
substrate specificity, regressions were developed for single ECOSAR classes, or 
for combinations of similar classes: Anilines (Aromatic Amines), Benzyl 
Alcohols, Esters and Amides/Imides. The compounds that did not belong to 
these well-defined classes were combined in a group called ‘remaining 
chemicals’. The vast majority of the chemicals in this group belong to the 
ECOSAR class Neutral Organics. The ECOSAR software defines Neutral Organics 
as compounds that are generally solvents, non-ionisable and non-reactive [63], 
thus including diverse chemicals. 
 
3.3 Results 
All regressions made for each combination of isoenzyme and/or species are 
reported in Tables 3.1-3.4, corresponding to ADH, ALDH, FMO and CYP, 
respectively. From here on, the equations are specified with their names, 
which describe the enzyme family and the isoenzyme, indicated by its number 
and/or the species, indicated by its first 3 letters. Appendix C (Tables C2-C5) 
provides a more complete overview of the regressions, including the 95% 
Confidence Interval (95%CI) for slopes and intercepts, as well as the Log (1/Km) 
and Log Kow ranges. 
Figure 3.1 (next page). Relationships between Log (1/Km) and Log Kow in 
mammals for compounds metabolised by: A) ADH; B) ALDH; C) FMO; D) CYP. 
Regressions (solid lines) and 95% confidence intervals (dashed lines). 
Laboratory measurements (dots): Log transformed geometrical mean of 1/Km 
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3.3.1 ADH 
We developed 7 equations for ADH, which are reported in Table 3.1. The slope 
of the general regression ADHgen (Figure 3.1A) was 0.6, and the observed Km 
data were between 10 and 106 μM. The specific regressions had a 
systematically lower explained variance compared to ADHgen (r2=0.56), except 
for ADH3_rat which had an r2 of 0.77. With pancova<0.05, the 2 regressions for 
ADH3 were statistically different from the general one; in particular, the 
intercepts were smaller. ADH dataset contained a large number of compounds 
classified as Neutral Organics (17 on a total of 33). They were mainly linear 
alcohols, while two compounds were classified as Benzyl Alcohols. 
Table 3.1. Relationships between Log Kow and Log (1/Km) for ADH. The Km 
values were expressed as μM. 







Regression made merging all species (mammals) and all isoenzymes 
ADHgen 0.59(±0.09) -3.36(±0.18) 34 0.56 0.82 <0.01 / 
Regressions for the separate species and the separate isoenzymes 
ADH1_hor 0.40(±0.11) -3.08(±0.24) 20 0.45 0.72 <0.01 0.96 
ADH1_hum 0.58(±0.12) -3.01(±0.23) 24 0.50 0.85 <0.01 0.13 
ADH2_hum 0.67(±0.19) -3.58(±0.41) 18 0.43 1.43 <0.01 0.70 
ADH3_hum 0.54(±0.25) -4.38(±0.58) 7 0.48 0.72 0.09 <0.01 
ADH1_rat 0.62(±0.19) -3.11(±0.32) 13 0.50 0.84 0.01 0.28 
ADH3_rat 1.18(±0.32) -6.57(±0.75) 6 0.77 0.82 0.02 <0.01 
Regression made merging all species and all isoenzymes, using Log D7.4 values 
ADHgen ionis 0.60(±0.10) -3.30(±0.18) 34 0.52 0.85 <0.01 / 
a The underlined value indicates non significant regression (p>0.05); b the 
underlined values indicate regressions significantly different from ADHgen 
(pancova<0.05). 
3.3.2 ALDH 
We initially built 9 QSARs for ALDH, which are reported in Table 3.2. The 
general equation ALDHgen (Figure 3.1b) had a slope of 0.7, and the observed 
Km data were between 10
-3 and 103 μM. Among the specific regressions, the 3 
equations for rat had r2 values lower than for human and horse (r2 between 0.4 
and 0.8). Compared to ALDHgen, the 3 equations for rat had pancova<0.05. For 
ALDHgen, 11 out of the total 77 compounds had observed Km values that were 





Nine of these outliers were substituted benzaldehydes. The ALDH dataset 
contained 22 substituted benzaldehydes, which are represented by white dots 
in Figure 3.1B and listed in Appendix C (Table C6), together with their general 
structures. 
We developed 3 additional general regressions leaving out the possibly 
influential data: I) substituted benzaldehydes; II) rat data; III) rat data as well as 
substituted benzaldehydes. The 3 additional regressions (Table 3.2) had a slope 
of 0.8 and r2 values larger than ALDHgen (r2=0.33). The exclusion of the 
substituted benzaldehydes significantly improved the correlation: the 
explained variance was increased to 63%, and SE was reduced from 1.33 to 
0.96. Similar statistic parameters were obtained when both rata data and 
substituted benzaldehydes were removed from the dataset. In order to discern 
the contribution of rat data to the weak correlations found for ALDH, we 
developed two more regressions: 1) including only rat data for ALDH 
metabolised compounds; 2) including only rat data and excluding substituted 
benzaldehydes. The results are reported in Appendix C (Table C7, Figure C1). 
No robust correlation was found between Log Kow and Log (1/Km) in rat, with 
explained variance of 6% and a slope of 0.16. The correlation was improved by 
the exclusion of substituted benzaldehydes, although it was still weak 
(r2=0.28). 
Table 3.2. Relationships between Log Kow and Log (1/Km) for ALDH, together 
with 3 additional general regressions leaving out the possibly influential data: I) 
substituted benzaldehydes; II) rat data; III) rat data as well as substituted 
benzaldehydes. The Km values were expressed as μM. 







Regression made merging all species (mammals) and all isoenzymes 
ALDHgen 0.69(±0.11) -1.18(±0.22) 77 0.33 1.33 <0.01 / 
Regressions for the separate species (mammals) and the separate isoenzymes 
ALDH1_hor 0.99(±0.30) -1.31(±0.38) 10 0.57 1.00 0.01 0.84 
ALDH2_hor 0.73(±0.35) -0.43(±0.43) 9 0.39 1.13 0.07 0.10 
ALDH1_hum 0.82(±0.08) -0.99(±0.17) 28 0.80 0.73 <0.01 0.19 
ALDH2_hum 0.86(±0.13) -0.73(±0.27) 57 0.42 1.17 <0.01 <0.01 
ALDH3_hum 0.54(±0.17) -1.18(±0.21) 12 0.51 0.74 0.01 0.95 
ALDH1_rat 0.18(±0.10) -1.33(±0.17) 32 0.10 0.73 0.08 <0.01 
ALDH2_rat 0.10(±0.17) -2.34(±0.26) 22 0.02 1.00 0.55 <0.01 
ALDH3_rat 0.56(±0.33) -3.80(±0.74) 8 0.32 0.45 0.14 <0.01 
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Continuation of Table 3.2 
Additional general regressions excluding possibly influential data: I) substituted 
benzaldehydes; II) rat data; III) rat data and substituted benzaldehydes s 
I 0.81(±0.09) -1.15(±0.17) 55 0.63 0.96 <0.01 / 
II 0.83(±0.10) -0.84(±0.20) 63 0.53 1.05 <0.01 / 
III 0.83(±0.09) -0.92(±0.19) 50 0.63 0.96 <0.01 / 
Regression made merging all species and all isoenzymes, using Log D7.4 values 
ALDHgen ionis 0.61(±0.12) -1.00(±0.23) 77 0.26 1.4 <0.01 / 
The underlined values indicate: anon significant regressions (p>0.05) 
bregressions significantly different from ALDHgen (pancova<0.05). 
3.3.3 FMO 
In most of the experiments in which FMO activity was measured, the 
isoenzyme investigated was not reported. Thus, it was possible to group the 
data by species (i.e. mouse and pig) only. For all 3 groupings (Table 3.3), no 
robust correlations were found between Log Kow and Log (1/Km), with r
2 values 
around 0.20. The general equation FMOgen (Figure 3.1C) had a slope of 0.2, 
and the observed Km data were between 1 and 10
5 μM. With 54% explained 
variance, the Log Kow correlated well with the affinity of OP pesticides 
(represented by black dots in Figure 3.1c), albeit with a shallow slope of 0.3. 
Table 3.3. Relationships between Log Kow and Log (1/Km) for FMO, together 
with an additional regression developed including organophosphorous (OP) 
pesticides only. The Km values were expressed as μM. 
Name Slope(±SE) Intercept(±SE) n r
2
 SE p pancova 
Regression made merging all species (mammals) and all isoenzymes 
FMOgen 0.22(±0.04) -2.52(±0.11) 149 0.20 0.88 <0.01 / 
Regressions for the separate species 
FMO_mou 0.21(±0.06) -2.24(±0.16) 45 0.23 0.80 <0.01 0.08 
FMO_pig 0.21(±0.04) -2.48(±0.12) 144 0.18 0.90 <0.01 0.80 
Regression for OP pesticides, merging all species and all isoenzymes 
 0.32(±0.09) -2.34(±0.33) 12 0.54 0.45 0.01 / 
Regression made merging all species and all isoenzymes, using Log D7.4 values 
FMOgen ionis 0.29(±0.04) -2.43(±0.09) 148
a
 0.31 0.82 <0.01 / 






For CYP, we first built 5 QSARs using all data (Table 3.4). The general equation 
CYPgen had a slope of 0.3 (Figure 3.1D); the observed Km data were between 1 
and 105 μM. Among the separate regressions for the ECOSAR classes, poor 
correlation was found for the group of diverse chemicals, ‘remaining 
chemicals’, with r2<0.1 and a slope of 0.2. Good correlations were found for 
the specific chemical classes, all significant at the 0.01 level and with r2 values 
ranging from 0.37 and 0.70. These regressions had slopes between 0.5 and 0.8. 
Table 3.4. Relationships between Log Kow and Log (1/Km) for CYP, together with 
5 additional general regressions for separate ECOSAR classes: I) Anilines 
(Aromatic Amines); II) Benzyl Alcohols; III) Esters; IV) Amides/Imides; V) 
‘remaining chemicals’. The Km values were expressed as μM. 





Regression made merging all species (mammals) and all isoenzymes 
CYPgen 0.34(±0.08) -3.38(±0.17) 121 0.13 0.82 <0.01 / 
Regressions made for the separate species and the separate isoenzymes 
CYP1A1_rat 0.52(±0.17) -3.63(±0.32) 23 0.30 0.54 0.01 0.75 
CYP2B1_rat 0.08(±0.21) -2.55(±0.48) 39 0.00 1.02 0.70 0.09 
CYP2B4_rab 0.24(±0.12) -3.39(±0.27) 47 0.08 0.76 0.05 0.12 
CYP2E1_rab 0.78(±0.10) -4.00(±0.16) 36 0.65 0.51 <0.01 0.94 
I. Regression for Anilines (Aromatic Amines), merging all species and all isoenzymes 
 0.77(±0.26) -4.19(±0.46) 17 0.37 0.51 0.01 / 
II. Regression for Benzyl Alcohols, merging all species and all isoenzymes 
 0.84(±0.20) -4.03(±0.32) 17 0.54 0.37 <0.01 / 
III. Regression for Esters, merging all species and all isoenzymes 
 0.84(±0.14) -4.48(±0.26) 17 0.70 0.54 <0.01 / 
IV. Regression for Amides/Imides, merging all species and all isoenzymes 
 0.48(±0.13) -3.03(±0.23) 14 0.54 0.43 0.01 / 
V. Regression for the remaining chemicals, merging all species and all isoenzymes 
 0.16(±0.13) -3.02(±0.33) 56 0.03 0.99 0.22 / 
Regression made merging all species and all isoenzymes, using Log D7.4 values 
CYPgen ionis 0.25(±0.07) -3.20(±0.15) 121 0.10 0.83 <0.01 / 
a The underlined values indicate non significant regressions (p>0.05). 
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3.3.4 Ionisation 
The general regressions developed for the four enzyme families using Log D7.4 
values are reported in the last row of Tables 1-4, as well as in details in 
Appendix C (Table C8 and Figure C2). The 54% of the compounds in FMO 
dataset had a dissociated fraction larger than 0.05 at pH 7.4; for the other 
enzyme families this percentage was 9% or lower. The correction for ionisation 
improved the results only for FMO, although the correlation was still weak 




The QSAR models presented in this paper were developed for a well-defined 
endpoint (Km), using an unambiguous algorithm that can be mechanistically 
interpreted, as recommended by OECD guidelines [64]. The relationship 
between Kow and 1/Km can be understood from partitioning theory. If weak 
interactions are dominant, the partitioning of organic chemicals over various 
phases is governed by hydrophobicity and polarity [65]. The lipophilicity 
parameter Log Kow combines these two properties [66]. A linear correlation 
was found between Log Kow and enzyme binding affinity, expressed as Log 
(1/Km), similar to the lipophilicity relationships noted for affinity to proteins 
[65]. The binding affinity increased with the compound Kow for 4 oxidising 
enzymes tested in vitro in mammals (Tables 3.1-3.4), i.e. the more lipophilic 
the substrate, the higher its affinity for the enzymes. However, a substantial 
number of correlations were weak and several were not statistically significant. 
In such cases, binding affinity may be mainly controlled by other interactions, 
e.g. of steric, covalent, or ionic nature. Therefore, the inclusion of descriptors 
related to these components may improve the QSARs. 
When available, we used experimental Kow data, otherwise the predicted ones 
[26]. The Michaelis constants (Km) were sourced from the open literature, so 
they come from different laboratories, often employing different protocols 
(e.g. conditions of pH and temperature) [67]. Consequently, the input data are 
subject to variation, implying uncertainty in the regressions. 
The datasets consisted of specific chemicals; in fact, the experimental Km data 
were taken from tests with compounds considered substrates of the enzymes. 
The applicability domains of the models are defined by the range (min and 
max) of Log Kow values of the compounds used to build the model, which are 
reported in Tables C2-C5 in Appendix C. Therefore, when using a regression for 
predicting the Km value of a new compound, it is important to know if the 





within the range established by the dataset. Furthermore, it is also 
recommended to check if the chemical belongs to one of the ECOSAR classes 
present in the dataset. 
We developed 24 QSARs, grouping the data according to 2 criteria: merging all 
species and all isoenzymes (4 general regressions, one for each enzyme group), 
and separating each combination of a species and isoenzyme. In most cases, 
the 4 general QSARs did not differ statistically from the specific ones: 
apparently, the patterns are generally applicable to different isoenzymes and 
species. The most remarkable exceptions were the equation for ADH3 and the 
3 equations for ALDH in rat. In a previous study on ADH kinetics [68], class 1, 2 
and 3 isoenzymes were shown to have common characteristics, such as 
substrate binding enhancement with increasing compound lipophilicity. 
Nevertheless, ADH3 is unique among the members of the ADH family, having 
kinetic properties identical to the glutathione-dependent formaldehyde 
dehydrogenase [69]. Regarding the regressions for ALDH in rat, Log Kow and Log 
(1/Km) were not strongly correlated. This may explain the difference with the 
general regression, built using also data from human and horse for which 
better correlations were found. 
We took into account the substrate’s dissociation at physiological pH (7.4) by 
using Log D7.4 as descriptor, which represents the lipophilicity corrected for 
ionisation of the chemical. The influence of ionisation to binding affinity was 
relevant only for compounds metabolised by FMO, for which the correlation 
with binding affinity increased, though slightly (r2 = 0.31 and slope = 0.3). 
Therefore, the inclusion of Log D7.4 did not contribute to improve the results 
significantly. 
3.4.2 Additional regressions 
We developed 9 additional QSARs including or excluding specific data. For 
ALDH, the general regression improved when rat data were excluded. In 
addition, it was found that the binding to ALDH of substituted benzaldehydes 
was not well described by Log Kow. These compounds had similar Log Kow 
values, ranging from 1.22 to 2.88, while their Log (1/Km) values covered 5 
orders of magnitude, between -2.51 and 2.49. In the work of Klyosov [70], the 
kinetics of ALDH towards various aldehydes was tested. Correlations between 
the Km of aldehydes and their hydrophobicity (expressed in terms of Hansch 
constant, π) were found for all compounds except substituted benzaldehydes. 
For FMO, significant correlations were found for OP pesticides only, albeit with 
a slope of 0.3, similar to the shallow slope of FMOgen. Five separate 
regressions were developed for ECOSAR classes in CYP. Good correlations were 
found for the specific chemical classes, but not for the group of diverse 
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chemicals (‘remaining chemicals’). In the same way, the regressions for single 
CYP isoenzymes gave good correlations when the datasets contained mainly 
specific chemical classes, i.e. Anilines and Amides/Imides for CYP1A1 and 
Benzyl Alcohols and Esters for CYP2B4. This would suggest that lipophilicity-
binding regressions for CYP isoenzymes depend on a chemical class-specific 
approach. Previous studies have investigated the relationship between 
lipophilicity and binding to CYP using homogeneous datasets. In Hansch’s 
review on CYP [26], QSARs were developed for single experiments (single 
isoenzymes) on specific classes of compounds. The overall picture emerging 
from these models was that hydrophobic drugs are attractive targets for CYP 
enzymes in mammals. In Appendix C (Table C9) we reported the regressions 
made with the data sets in Hansch’s review, which were adapted using Log Kow 
(experimental value, if available) as sole descriptor and Km expressed in μM. 
Among the 14 data sets, 7 gave acceptable regressions (n>6, p<0.05, 
underlined in Table C7). In the work of Lewis and Dickins [71], QSARs were 
developed using Km data collected from different enzyme assays on drugs. For 
a given P450 isoenzyme and for a set of substrates, a linear relationship 
between binding and compound lipophilicity was observed. It was described as 
linear free energy relationship, which is frequently encountered in biological 
systems. This linear relationship was not true for all compounds, possibly 
because of additional binding interactions involved that are not in common 
with those of the other substrates. Therefore, other descriptors are needed 
when a fairly large number of structurally diverse substrates are examined for 
a given P450 isoenzyme [30]. 
3.4.3 Mechanistic explanation 
Lipophilicity was relevant to binding affinity for most of the substrate classes of 
ADH, ALDH and CYP, with the 95% CIs of the slopes (Tables C2, C3 and C5 in 
Appendix C) covering the value of 0.63, which is the typical slope correlating 
protein-water distribution (Log Kpw) and Log Kow [65]. The value of 0.63 is in 
accordance with the slopes observed in other Log Kow-Log Kpw relationships, 
e.g. 0.57 (for chemicals with Log Kow ranging from 2.0 to 5.1) [72] and about 0.7 
[73]. A gentle slope was found for all regressions developed for FMO (b=0.21-
0.32). If strong interactions, such as covalent or ion bonds, are important, 
distribution of chemicals is expected to be weakly related to their Kow [65]. 
While the slope of the lipophilicity relationship provides an indication of the 
lipophilic character of the substrate binding, comparison of the intercepts 
indicates that at Log Kow = 0, 1/Km is about 100 times higher for ALDH than for 
the other enzymes family, with b of -1 and about -3, respectively. 
The strength of the interactions depends on the reactions that the enzymes 





primary and secondary alcohols and oxidises them to aldehydes and ketones, 
respectively. ALDH metabolises endogenous and exogenous aldehydes to 
carboxylic alcohols (hydroxylation) [13]. FMO catalyses oxygenation of soft 
nucleophiles, i.e. compounds with functional groups bearing a polarisable, 
electron-rich centre, usually a heteroatom (such as nitrogen, sulphur and 
phosphorus) in organic compounds [74]. The poor correlation found for FMO 
could be attributed to its catalytic cycle, which is different with respect to the 
other enzymes [58]. FMO is a flavin protein containing a single FAD, which is 
first reduced and then reacts with molecular oxygen to form a peroxy-flavin 
(FADOOH), which can subsequently react with the substrate. The nucleophilic 
attack on the FADOOH results in the transfer of 1 atom of molecular oxygen on 
the substrate. The access to the FADOOH intermediate could be better 
predicted by descriptors such as electronic properties rather than lipophilicity. 
CYP is involved in the metabolism (primarily oxidative) of a vast number and 
wide structural variety of compounds [49]. In an extensive study on CYP3A4 
[75], among the various types of mediated reactions, the best lipophilicity-Km 
correlation was achieved for carbon hydroxylation, while no or little 
correlations were seen for N-, S-oxidation and other reactions. Also in our 
study, hydroxylation (mediated by ALDH) gave the best regressions, while for 
N-, S-oxidation (mediated by FMO) a poor correlation was found between Km 
and Kow. 
3.4.4 Application 
The regressions obtained in the present study relate the enzyme binding with 
Log Kow, the descriptor which is commonly used in bioaccumulation models. 
Information on both Km and Vmax is essential for the extrapolation from in vitro 
to in vivo metabolism, required for risk assessment. In fact, for reactions that 
exhibit Michaelis-Menten kinetics and on condition of non-saturating substrate 
concentration, the ratio between Vmax and Km provides an estimation of the 
intrinsic clearance (CLint) [19, 76]. This parameter, which is a measure of 
enzyme activity towards a compound, can be extrapolated to equivalent 
whole-body metabolic rate [77]. Yet, in order to apply these regressions to 
predict whole-body metabolic rates, improvements are needed at various 
points. Firstly, the explained variance (r2) of the present regressions can be 
increased by extending the number of descriptors included, such as hydrogen-
bond descriptors. In addition, other investigations are required to predict Vmax, 
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Appendices 
Appendix B provides original Km data.  
Appendix C provides regressions including 95% CI intervals, Log Kow and Log 
(1/Km) ranges, regressions for rat data (ALDH), regressions using Log D7.4 values 
and regressions for single CYP experiments, as well as additional tables listing 
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The bioaccumulation potential of chemicals in organisms is a vital element in 
environmental risk assessment [1]. The accumulation of a chemical is the result 
of a series of physiological and physical processes: absorption, distribution, 
metabolism and excretion (ADME). Metabolism, also referred to as 
biotransformation in the case of xenobiotics [1], occurs via enzymatic reactions 
involving two processes. Firstly, the chemical needs to reach the enzyme and 
bind to it; secondly, a catalytic reaction has to take place. The latter process is 
described by the maximum rate of reaction (Vmax) at saturating substrate 
concentration [25]. Alternatively, Vmax can be expressed as turnover number 
(kcat, with units of time
-1), which represents the number of substrate molecules 
converted into product per enzyme molecule per time, when the enzyme is 
saturated with substrate [78]. The other parameter used to characterise an 
enzymatic reaction is the Michaelis-Menten constant Km, which is the substrate 
concentration at half Vmax. Km is equal to the ratio (kcat + k_1)/k1, where k_1 and 
k1 are constants, respectively, for breakdown and formation of the complex 
enzyme-substrate (ES) [24]. If kcat is smaller than k-1, Km is assumed to be equal 
to the dissociation constant Kd for the ES complex. In this case, 1/Km reflects 
the affinity of the enzyme for its substrate: a low Km (or high 1/Km) corresponds 
to high binding affinity. For reactions that exhibit Michaelis-Menten kinetics 
and at non-saturating substrate concentrations, the ratio Vmax/Km provides an 
estimation of the intrinsic clearance (CLint) [19, 76]. CLint, which is a measure of 
enzyme activity toward a compound, can be extrapolated to an equivalent 
whole-body metabolic rate, required for risk assessment [77]. 
Several studies [26, 27] have shown the importance of Quantitative Structure-
Activity Relationships (QSARs) for the investigation of Km and Vmax, most of 
which focused on drugs oxidised by cytochrome P450 (CYP). The binding to the 
enzyme, represented by 1/Km, was shown to be mainly related to compound 
hydrophobicity [25, 28], probably due to desolvation effects, although 
electronic and geometric factors, such as polarity and size, can also be 
important [27]. The rate appears to be influenced by electronic properties, 
such as frontier orbital energies or hydrogen bonding properties [29-31]. In 
fact, catalytic processes are characterised by cleavage and formation of 
covalent bonds [25]. However, the above-mentioned studies focussed on 
particular series of P450 substrates, implying applicability only for specific 
combinations of chemicals and P450 enzymes. Recently, Pirovano et al. [79] 
studied the relationships between 1/Km and hydrophobicity, i.e. the octanol-
water partitioning coefficient (Kow), for a broader set of chemicals and oxidising 
enzymes in mammals. The chemicals investigated were xenobiotics such as 
alcohols, aldehydes, drugs and pesticides. The enzymes examined, in addition 
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to CYP, were alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH) 
and flavin-containing monooxygenase (FMO). 
In the present study, we extended our analysis to other descriptors, which 
were chosen on the basis of mechanistic considerations. Furthermore, we did 
not only investigate descriptors for 1/Km, but also for Vmax. The aim of the 
current study was to develop QSARs with Log (1/Km) and Log Vmax as endpoints 
for ADH, ALDH, FMO and CYP enzymes in mammals. General linear models 
were built with descriptors related to partitioning, as well as geometric and 
electronic properties of the substrates. 
 
4.2 Materials and methods1 
4.2.1 Experimental dataset 
Data collection 
Km and catalytic reaction rates (expressed either as Vmax or kcat) were taken 
from peer-reviewed articles. We considered the following enzymes: alcohol 
dehydrogenase (ADH), aldehyde dehydrogenase (ALDH), flavin-containing 
monooxygenase (FMO) and cytochrome P450 (CYP). For ADH and ALDH, data 
were taken from the BRENDA enzyme database [57] (BRaunschweig ENzyme 
DAtabase, http://www.brenda-enzymes.org). Metabolic constants for FMO 
were taken from a review [58] and references contained therein. Data for CYP 
were sourced from other reviews [26, 59, 60]. All data extracted from the 
BRENDA database and the reviews were checked in the original papers. 
Constants measured for mammals in in vitro assays of purified, non-
recombinant, hepatic enzymes were selected. For each value, we recorded the 
species and the enzyme for which it was measured and the experimental 
conditions such as pH and temperature. Rate values were not reported in one 
article on ALDH [80] and six articles on FMO [81-86], in which only Km values 
were measured for a total of 5 and 75 compounds, respectively. The substrates 
collected are mainly drugs and compounds found in the environment. 
SMILES (Simplified Molecular Input Line Entry System) strings [61] and CAS 
(Chemical Abstract Service) numbers were obtained from the ChemSpider 
website (http://www.chemspider.com/). Each compound was assigned to a 
relevant chemical class using ECOSAR v 1.0, a program present in the EPI Suite 
of the US Environmental Protection Agency (EPA) (http://www.epa.gov) [87]. 
                                                          
1 In the original paper, a shortened version of the Materials and Methods 
section was present. The extended version present in this thesis was reported 





The data collected can be found in Appendix B (Table B1), with the references 
to the original papers. 
Data treatment 
Michaelis constants (Km) were expressed in μM. Since catalytic rates were 
reported in heterogeneous units and with different constants (i.e. as Vmax or as 
kcat), it was necessary to standardise the data. We expressed all rates as Vmax, 
using μmol min-1 mgPROT
-1 as units. For CYP enzymes, assays were performed 
isolating microsomal fractions and inducing the activity of the P450 isoenzyme 
of interest by treating the animals with various agents, such as Phenobarbital 
for CYP2B1 in rat [88]; Vmax was then referred to the microsomal protein 
weight, i.e. mgPROT=mgMICR PROT. For the other enzymes, Vmax was referred to the 
weight of the enzyme being studied, i.e. mgPROT=mgENZ, as the assays were 
performed with isolated and purified liver enzymes. The rates expressed as kcat 
were transformed into Vmax values. For ADH, ALDH and FMO, we derived Vmax 
(expressed as μmol min-1 mgENZ
-1) dividing kcat (min
-1) by the molecular weight 
of the enzyme (Mr, mgENZ μmol
-1). For CYP, we transformed kcat (min
-1) into Vmax 
values (expressed as μmol min-1 mgMICR PROT
-1) multiplying the former by the 
specific content of the enzyme (E, μmol mgMICR PROT
-1) [29]. If Mr or E values 
were not reported in the paper where we collected kcat, we used average 
values coming from other studies. The operations performed on the data are 
reported in detail in Appendix B, Table B2. The Vmax values expressed in μmol 
min-1 mgPROT
-1 and used in this study are reported in Appendix B, Table B1, 
together with the original rate values. 
Michaelis constants (Km) and maximum rates (Vmax) of different substrates 
were combined into 4 datasets, one for each enzyme family. Each substrate 
was characterised by a single value of 1/Km or Vmax; if multiple values were 
available for one substrate, we calculated the geometric mean of the 
experimental 1/Km or Vmax values, as well as the geometric standard deviation.  
4.2.2 Descriptors and QSAR models 
Descriptor calculation and selection 
We compiled a list of physicochemical descriptors based on mechanistic 
considerations. We anticipated 1/Km and Vmax to be related to the partitioning, 
geometric and electronic properties of the substrates of P450 [29, 59, 66, 89]. 
Therefore, we collected the descriptors (18 in total) used in the QSARs for Log 
(1/Km) or Log Vmax in the above-mentioned studies. We hypothesised that they 
could be applied to all four enzyme classes, as they were among the 
descriptors commonly used to describe biological responses to xenobiotics 
[90]. The descriptors were computed with Chemaxon 
(http://www.chemaxon.com) through the OCHEM platform [91] 
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(http://ochem.eu) and with the semi-empirical molecular orbital program 
MOPAC2009 [92] (Hamiltonian AM1) using the software Vega ZZ [93] v2.4.0 
(http://vegazz.net). For the calculation of all descriptors, the molecular 
conformations were optimized with MOPAC. A correlation matrix was 
calculated on all compounds as a first screening to detect collinear descriptors, 
i.e. descriptors with correlation coefficients (R) higher than 0.8 or lower than -
0.8. Among the collinear descriptors, we retained the one that we considered 
easier to interpret mechanistically. 
The final set of descriptors is reported in Table 4.1, together with the software 
used to compute them. The partitioning was expressed with the octanol water 
partitioning coefficient of the uncharged molecule (logP). The geometrical 
descriptors of the chemicals were molecular area (A), i.e. length times width, 
ratio of molecular length to molecular width (l/w) and ratio of the area of the 
molecule to the square of depth (a/d2). Length, width and depth of a molecule 
represent molecular dimensions measured orthogonally relative to the main 
molecular plane [94]. The electronic parameters were the strongest acidic and 
strongest basic pKa (apKa1 and bpKa1, respectively), hydrogen bond donor and 
acceptor (HBD and HBA, respectively), dipole moment (ν), final heat of 
formation (Hf), energy of the highest occupied molecular orbital and energy of 
the lowest unoccupied molecular orbital (EHOMO and ELUMO, respectively) and 
the difference between the frontier orbital energy levels (ΔEL-H = ELUMO - EHOMO). 
The descriptors were auto-scaled to zero-mean and unit-variance to ensure 
equal contribution of all variables in the models. 
Model development 
General linear models (GLM) were developed for Log (1/Km) and Log Vmax with 
the software R v.2.15.1 [95] (http://www.R-project.org). We used the R 
package ‘bestglm’ [96] to select the best subset of variables for the linear 
regression after an exhaustive search, i.e. all possible combinations of 
descriptors were generated and tested by the algorithm. In order to avoid 
overfitting, we set the maximum number of variables to be included in the 
subsets at 6. It is generally recommended that the ratio of number of 
compounds to the number of descriptors in the QSAR should be at least 5:1 
[97]. The best model was then chosen based on the Akaike’s Information 
Criterion (AIC). The AIC is a trade-off between a good fit to the model 
(measured by the likelihood) and a penalty for complexity (calculated using the 
number of parameters). The model with the lowest AIC is interpreted as the 
best model. We performed a final check for collinearity of the descriptors in 
the individual QSARs using variance inflation factors (VIFs). We used the R 
package ‘car’ [98] to calculate the VIFs for the variables included in each QSAR 





VIF>3 [99]. If all variables had VIFs<3, the QSAR was accepted; otherwise, the 
variable with the highest VIF was removed from the dataset and the ‘bestglm’ 
method was performed again. The VIF values were then recalculated and this 
procedure was repeated until all VIF values were smaller than the threshold 
[100]. 
The models were cross-validated with the leave-one-out (LOO) procedure 
using WEKA v.3.6.7 [101] (http://www.cs.waikato.ac.nz). With the LOO cross 
validation, a single observation is removed from the original dataset, and the 
remaining observations are used as training data, in such a way that each 
observation is removed only once. Then one model is developed for each data 
set, and the response values of the removed observations are predicted from 
these models. 
For each model, we report the coefficient of determination (R2) and the Root 
Mean Squared Error (RMSE) as measures of the fitting. The adjusted 
coefficient of determination (R2adj) is shown in order to adjust the R
2 value for 
the number of explanatory variables in the model. The fitting of the models is 
also evaluated based on the p-value from the F-test (p). We report the LOO 
cross-validated R2 (Q2LOO) and RMSE (RMSELOO) to assess the predictive power 
of the models. The formulas of these coefficients are presented in Appendix B. 
In the equations of the QSARs, we show the standardised coefficients of the 
variables (i.e. the regression coefficients that do not depend on the units and 
that were obtained using the auto-scaled descriptors) together with their 
errors and p-values. 
Additional regressions 
In our previous work on the relationship between 1/Km and lipophilicity [79], 
we observed two groups of compounds that were outliers: 22 substituted 
benzaldehydes for ALDH (listed in the Appendix C, Table C6) and 52 ‘non 
specific’ chemicals for CYP (mainly Neutral Organics, according to the ECOSAR 
classification). Therefore, in this work we also investigated the possible 
influence of these classes of compounds in the QSARs. We developed two 
additional sets of QSARs for both ALDH and CYP: one with all compounds 
except the group of outliers (ALDH1 and CYP1) and one with only the group of 
outliers (ALDH2 and CYP2). For the QSARs with the 22 substituted 
benzaldehydes, the maximum number of variables to be selected by the 
algorithm was set to 4, due to the relatively low number of compounds. We 
also developed an overall regression for Log (1/Km), merging all data from the 4 
datasets and adding a qualitative variable called “Enzyme” with four categories 
(ADH, ALDH, FMO, CYP) representing the enzyme group of the data point.  
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Table 4.1. Descriptors used to develop the QSARs. 
Symbol Units Description Type Software 
logP [-] 






Van der Waals surface area, 






 Geometric MOPAC 
l/w [-] length/width 
a
 Geometric MOPAC 
apKa1 [-] Strongest acidic pKa Electronic Chemaxon 
bpKa1 [-] Strongest basic pKa Electronic Chemaxon 
HBD [-] 




Hydrogen bond acceptor, calculated 
at pH 7.4 
Electronic Chemaxon 
ν [Debye] Dipole moment Electronic MOPAC 
EHOMO [eV] 
Energy of the highest occupied 
molecular orbital (HOMO) 
Electronic MOPAC 
ELUMO [eV] 
Energy of the lowest unoccupied 
molecular orbital (LUMO) 
Electronic MOPAC 
ΔEL-H [eV] ΔEL-H = ELUMO - EHOMO Electronic MOPAC 
Hf [kcal/mol] Final heat of formation Electronic MOPAC 
a Length, width and depth of a molecule represent molecular dimensions 
measured orthogonally relative to the main molecular plane (35). 
 
4.3 Results 
The QSARs developed for Log (1/Km) and Log Vmax are presented in Tables 4.2 
and 4.3, respectively, with the standardised regression coefficients (i.e. the 
regression coefficients that do not depend on the units and were obtained by 
using the auto-scaled descriptors). The non-standardised regression 
coefficients and the overall regression for Log (1/Km) and Log Vmax can be found 
in the Appendix D, Tables D1-D2. As an example, Figure 4.1 represents the 





Figure 4.1 Measured versus predicted values for a) Log (1/Km) and b) Log Vmax, 
for compounds metabolised by ADH in mammals. The solid lines indicate the 
1:1 bisector and the dashed lines indicate ± 2 Log units error. Laboratory 
measurements (dots) for each compound: Log transformed geometrical mean 
of a) 1/Km [μM
−1] and b) Vmax [μmol∙min
-1·mgPROT
-1], with the geometric 
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4.3.1 Log (1/Km) 
Significant correlations (p<0.05) were obtained for all QSARs for Log 1/Km 
(Table 4.2), whose R2adj and Q
2
LOO varied from 0.37 to 0.74 and from 0.30 to 
0.72, respectively. The most common descriptors were area (A), octanol-water 
partitioning coefficient (logP) and difference between frontier orbital energies 
(ΔEL-H). The area had positive regression coefficients, ranging from 0.25 to 1.02. 
The coefficients of logP and ΔEL-H had positive and negative signs, respectively, 
in all cases, except for ALDH2 (QSAR with only the 22 substituted 
benzaldehydes) and ALDH (only for ΔEL-H). These 3 descriptors were the most 
important ones, i.e. with the highest standardised coefficients, in most of the 
QSARs: the area for ALDH, ALDH2 and CYP1 (QSAR without the ‘remaining 
chemicals’); logP for ADH, ALDH1 (QSAR without the 22 substituted 
benzaldehydes); ΔEL-H for CYP. The hydrogen bond acceptor (HBA) had the 
highest standardised regression coefficient (-0.42) in the QSAR for FMO. 
4.3.2 Log Vmax 
Correlations significant at the 0.05 level were obtained for all QSARs for Log 
Vmax (Table 4.3). The goodness of fit and the internal predictivity were lower for 




LOO varying from 0.17 to 
0.48 and from 0.12 to 0.41, respectively. The most common descriptor, 
appearing in six out of eight QSARs, was the dipole moment (ν), with 
coefficients ranging from -0.42 to 0.36. It was also the most important 
descriptor in the QSARs for ALDH1 and CYP1. The area (A) featured in four 
QSARs with a positive regression coefficient; it had the highest standardised 
coefficient (0.37) in the QSARs for ALDH and ALDH2. LogP occurred in three 
QSARs with a negative regression coefficient and, with a standardised 
coefficient of -0.27, it was the most important descriptor for ALDH1, together 
with the dipole moment. Among the other descriptors, apKa1, HBA and ELUMO 
had the highest correlation coefficients for FMO (-0.15), CYP2 (-0.29) and ADH 
(-0.44), respectively. Hf was the most important descriptor for CYP, with a 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In this study, QSAR models were developed for Log (1/Km) and Log Vmax of four 
groups of mammalian enzymes. We used relevant physicochemical descriptors 
reflecting hydrophobic, geometric and electronic properties of the chemicals. 
Common features were found within the QSARs for Log (1/Km) and Log Vmax, 
despite the different reaction types of the four enzymes considered. Log (1/Km) 
was largely controlled by hydrophobicity (logP), as well as area (A) and frontier 
orbital energy (ΔEL-H), while the rate (Vmax) was mainly influenced by electronic 
parameters, such as dipole moment (ν), hydrogen bonding properties (HBD 
and HBA) and energy of the lowest occupied molecular orbital (ELUMO). The 
difference in the molecular properties controlling Log (1/Km) and Log Vmax was 
expected from the nature of the processes underlying these two constants. 
The inverse of Km is usually assumed to be equal to the affinity constant for 
enzyme binding, which is generally a desolvation process; thus, it is controlled 
mainly by hydrophobicity. Yet, this equivalence is valid only if the enzymatic 
process is composed of two steps - formation of the ES complex and successive 
catalysis - and if the latter is lower than the dissociation of the substrate from 
the enzyme. The Vmax represents the catalytic process, which is characterised 
by the cleavage and formation of covalent bonds; thus, it is more influenced by 
electronic properties of the substrates [25]. 
The variability explained by the QSARs ranged from 20% to 70% (R2adj in Tables 
4.2 and 4.3). The correlations improved substantially for Log (1/Km) by leaving 
out distinct substance groups such as substituted benzaldehydes. Weak 
correlations may indicate that the underlying catalytic reactions are complex 
and only partly related to the physicochemical descriptors chosen [102]. The fit 
of the QSARs could be improved by using theoretical molecular descriptors, i.e. 
calculated by mathematical formulae or computational algorithms [103], which 
are able to represent other aspects of molecular structures, such as topological 
indices and functional group counts. Yet, we did not include these descriptors 
in the present paper, because the objective was to allow for the mechanistic 
interpretation of the QSARs. 
The QSARs in the present work had lower R2 values in comparison to the 
QSARs for CYP developed in other studies, whose R2 values were around 0.8-
0.9 [26, 27, 29, 59]. Yet, the latter datasets typically included homologous 
series of about ten structurally-related compounds, metabolised by a given 
isoenzyme in one mammalian species. Thus, those models are applicable only 
to very specific combinations of compounds, isoenzymes and species, for 
which a similar behaviour can be expected. 
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The datasets consisted of compounds assigned to ECOSAR classes and known 
to be substrates of the enzymes considered in this study. The applicability 
domains of the QSARs are defined by the range (min and max) of the values of 
the descriptors used to build the model [104], which are reported in Tables D3 
and D4 in Appendix D for Log (1/Km) and Log Vmax, respectively. 
The experimental data come from different laboratories, often employing 
different protocols [67], e.g. for pH and temperature conditions, which can 
affect enzyme activity [78]. In addition, the rates were reported in the papers 
either as Vmax or kcat values. The latter were transformed into Vmax (Appendix B, 
Table B2) by using the conversion factors reported in the papers from which 
we collected kcat, when available; otherwise, we used average values obtained 
in other studies. Consequently, the input data are subject to variation, implying 
uncertainty in the QSARs. Furthermore, we merged data measured for 
different mammalian species (human, horse, rat, mouse, pig and rabbit) and 
isoenzymes (i.e. any of the several forms of an enzyme, all of which catalyse 
the same reaction but are characterised by different properties). This can be 
another source of unexplained variation; however, the focus of the present 
work was on general features in the metabolic process. 
We built four general QSARs each for Log (1/Km) and Log Vmax, one for every 
enzyme. In our previous study [79] on the relationships between 
hydrophobicity and Log (1/Km), we found an improvement of the regressions 
after the removal of two groups of influential chemicals: 22 substituted 
benzaldehydes for ADH and 56 ‘remaining chemicals’ (chemicals belonging to 
non-specific ECOSAR classes, mainly Neutral Organics) for CYP. Hence, in the 
present study, we developed four additional QSAR sub-models each for Log 
(1/Km) and Log Vmax, one without and one with only the groups of influential 
chemicals. For ALDH, the fitting increased with respect to the general QSAR 
only for the sub-model built for Log (1/Km) excluding the substituted 
benzaldehydes (ALDH1). For both endpoints, the most important descriptor 
was the area for the substituted benzaldehydes and logP for the other 
aldehydes. For CYP, this subdivision lead to QSAR sub-models with improved 
fitting for both Log (1/Km) and Log Vmax, although for the latter the Q
2
LOO values 
were low (around 0.2). It appears that the enzymatic constants can be 
dependent on chemical classes. The ‘remaining chemicals’ for CYP may have 
different abilities to fit onto and interact with the enzyme active site. 
4.4.2 Mechanistic explanation 
The QSARs developed in this work were generally in line with previous studies 
on enzyme metabolism, mainly concerning P450 enzymes [27]. In the following 
paragraphs, the influencing descriptors in the QSARs are explained in relation 





transformation of alcohols to the corresponding aldehydes or ketones. ALDH 
enzymes oxidise a wide range of aldehydes to their corresponding carboxylic 
acids [105]. FMO oxygenates various xenobiotics, such as pesticides and drugs, 
containing a nucleophilic heteroatom (usually sulphur and nitrogen) [58]. The 
oxygen abstraction takes place before binding via a nucleophilic attack by the 
substrate. The CYP enzymes usually catalyse mono-oxygenase reactions 
involving the insertion of an oxygen atom into a substrate [29]. 
The hydrophobicity (logP) featured in many QSARs for Log (1/Km), for which it 
had a positive correlation coefficient, with the exception of the QSAR for 
‘substituted benzaldehydes’. The increase of 1/Km with compound 
hydrophobicity is likely to indicate the importance of weak interactions such as 
substrate binding via desolvation processes, i.e. displacement of water 
molecules due to the binding of the substrate in the active site [106]. The 
different behaviour of substituted benzaldehydes was observed in our 
previous work relating Log (1/Km) to compound hydrophobicity (relationships 
shown in Appendix D, Tables D5-D6). In the work of Klyosov [70], correlations 
between the Km of aldehydes and their hydrophobicity (expressed in terms of 
Hansch constant, π) were found for all aldehydes tested except substituted 
benzaldehydes. In our QSARs for Log Vmax, logP featured only in three QSARs, 
which is in accordance with the common understanding that rates are not 
likely to be influenced by partitioning properties. In addition, logP had a 
negative coefficient for Log Vmax, indicating that hydrophobicity disfavours the 
catalysis of the substrates. 
Geometric properties of the substrates were included in several QSARs, the 
most frequent being the molecular area (A), always with a positive regression 
coefficient. The area was often the most important descriptor for Log (1/Km), 
and its contribution might be explained in two possible ways. First, larger 
dimensions increase the possibility of interactions with the binding site, which 
is an effect purely related to size. In addition, the area can be an indicator of 
compound hydrophobicity, as large molecules are often more hydrophobic. 
Thus, in the QSARs for Log (1/Km), the presence of the area reconfirmed the 
hydrophobic nature of the binding sites of the enzymes. For FMO and CYP, the 
area featured in the QSARs for 1/Km, but the most important descriptors were 
related to electronic properties. In these cases, 1/Km may not be an indicator of 
binding, as it describes stronger interactions. The catalytic mechanism of FMO 
involves a nucleophilic attack, which takes place before binding [58]. CYP 
enzymes have a catalytic mechanism with many steps occurring between 
binding and substrate oxygenation [49]. It was shown that Km values may be 
sensitive to kinetic perturbations at catalytic steps taking place after substrate 
binding; thus, 1/Km values may not be good approximations of affinity 
constants [107]. The electronic descriptors related to protonation (apKa1 and 
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bpKa1) featured in many QSARs, especially the acidic dissociation constant, 
which had negative regression coefficients for Log (1/Km). This means that 1/Km 
is higher for more acidic compounds (i.e. with lower pKa). The ionisation 
constant was a relevant factor also in QSARs for microbial biodegradation 
[108], due to the importance of protonation for enzyme-substrate interactions, 
as well as for penetration of the compound through the lipid bilayer. Electronic 
descriptors, such as HBD, HBA and dipole moment (ν), featured quite often 
especially in the QSARs for Log Vmax. This indicates that hydrogen bonding and 
polarity may play a significant role in the substrate-enzyme interactions. 
In our study, we included frontier orbital parameters associated with 
metabolic properties: the energy of the lowest unoccupied and of the highest 
occupied molecular orbital, i.e. ELUMO and EHOMO, respectively, together with 
their difference (ΔEL-H). ELUMO and EHOMO measure the ability of a molecule to 
accept and to donate an electron pair, respectively; thus, they describe the 
electrophilicity and the nucleophilicity of the substrate [109]. The difference 
ΔEL-H is a stability index: the higher ΔEL-H, the higher the compound reactivity in 
chemical reactions. In fact, it is the relative difference between the nucleophile 
and electrophile orbitals that governs the reactivity of a given nucleophile-
electrophile interaction [110]. EHOMO appeared only in the QSAR of Log Vmax for 
FMO, with a positive coefficient, as expected from its catalytic cycle. The 
substrates of FMO are nucleophiles, i.e. electron donors [58], and the higher 
the HOMO energy, the greater is the ability of the chemical to act as an 
electron donor. ELUMO and ΔEL-H featured in QSARs both for Log (1/Km), 
generally with a negative correlation coefficient and for Log Vmax, with a 
positive correlation. This could be explained with the kinetics of the Michaelis-
Menten reactions. Both Km and Vmax can be expressed in terms of kcat: Vmax is 
the product of kcat and total enzyme concentration, and Km is equal to the ratio 
(kcat + k_1)/k1, where k_1 and k1 are constants, respectively, for breakdown and 
formation of the complex enzyme-substrate [24]. The more reactive the 
molecule (i.e. the higher ΔEL-H), the higher is the catalytic rate (kcat), therefore 
the lower 1/Km (negative coefficient) and the higher Vmax (positive coefficient). 
The presence of ELUMO in the QSARs for Log Vmax for ADH, ALDH and CYP 
indicates that their substrates are likely electrophilic in nature, as it can be 
expected from their metabolic reactions. For ADH, a network of hydrogen 
bonding interactions facilitates the deprotonation of the alcohol substrate 
bound to the active site of the enzyme [111]. The ALDH catalytic mechanism 
involves a nucleophilic attack on the carbonyl group (C=O) of the aldehydes 
[112], which are reactive electrophilic compounds. At the CYP active site, the 
oxidation of chemicals is carried out by an electron-deficient complex (FeO3
+), 
which abstracts either a hydrogen atom or an electron from the substrate [49]. 





bases (H-acceptors). In fact, together with ELUMO, also pKa and hydrogen 
bonding properties were important in the QSARs for Log Vmax in CYP. 
 
4.5 Conclusions 
The QSARs developed in this study for Log (1/Km) and Log Vmax of four 
important oxidising enzymes included physicochemical descriptors, which can 
be calculated and interpreted in a straightforward way. The processes 
underlying biotransformation were discussed from a mechanistic point of view, 
which may be useful in future research aimed at the prediction of the 
clearance of chemicals. 
 
Appendices 
Appendix B contains the datasets collected for this study, as well the formulas 
of the statistical parameters used to assess model fitting and predictivity. 
Appendix D contains the non-standardised regression coefficients and the 
applicability domains of the QSAR models. 
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Information regarding the biotransformation of xenobiotics is essential for 
environmental toxicology, risk assessment and drug development because 
metabolism can largely influence the residence time and bioaccumulation of 
chemicals in organisms [1, 113]. Through biotransformation, the parent 
compound (substrate) is converted by enzymes into another chemical 
(metabolite), which is usually more soluble and thus can be excreted more 
easily. Metabolism occurs via enzymatic reactions involving two processes. 
Firstly, the chemical needs to reach the enzyme and bind to it; secondly, a 
catalytic reaction must occur. The latter process is described by the maximum 
rate of reaction (Vmax) at saturating substrate concentration [25]. The other 
parameter used to characterise an enzymatic reaction is the Michaelis-Menten 
constant (Km), which is the substrate concentration at half the maximum rate, 
i.e. at Vmax/2. If the catalytic step is slow compared with the dissociation of the 
substrate from the enzyme, Km is assumed to be equal to the dissociation 
constant Kd for the enzyme-substrate complex. In this case, the inverse of the 
Michaelis-Menten constant (1/Km) reflects the affinity of the enzyme for its 
substrate: a high 1/Km corresponds to high binding affinity. For reactions that 
exhibit Michaelis-Menten kinetics and at non-saturating substrate 
concentrations, the ratio between Vmax and Km estimates intrinsic clearance 
(CLint). Intrinsic clearance, which is a measure of enzyme activity towards a 
compound, can be extrapolated to an equivalent whole-body metabolic rate 
required for risk assessment [19, 114]. 
Measured Km and Vmax values are lacking for many chemicals and species. In 
silico methods, such as Quantitative Structure Activity Relationships (QSARs), 
can be useful tools for predicting biological transformation rates on the basis 
of chemical descriptors [115]. In previous studies, metabolic constants were 
frequently found to correlate with easily interpretable physicochemical 
properties of substrates, such as hydrophobicity or hydrogen bonding [116]. 
However, the reported QSARs had generally low explained variances [117] or 
considered only a limited series of substrates [26]. Weak correlations indicated 
that the metabolic processes could only partly be explained by the 
physicochemical descriptors chosen, possibly because of the complexity of the 
underlying metabolic reactions [102]. In the present study, we included a large 
number of theoretical molecular descriptors (approximately 2000), such as 
topological indices and functional group counts, which can capture the 
structural and molecular information of chemicals [118]. The use of theoretical 
molecular descriptors in QSAR models is helpful to identify the chemical 
features influencing the biological activities of large sets of diverse chemicals. 
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The aim of this study was to develop QSARs for the affinity constant (1/Km) and 
maximum reaction rate of xenobiotics transformed by the alcohol 
dehydrogenase (ADH), aldehyde dehydrogenase (ALDH), flavin-containing 
monooxygenase (FMO) and cytochrome P450 (CYP) enzymes in mammals. The 
QSARs were built with multiple linear regressions (MLR) by selecting 
theoretical descriptors with genetic algorithms. The QSARs were 
mechanistically interpreted to provide insight into the processes governing 
biotransformation. External validation was applied to assess the predictive 
power of the models. 
 
5.2 Materials and Methods 
5.2.1 Experimental dataset 
The enzymatic constants (Km and Vmax) were collected from the scientific 
literature for alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH), 
flavin-containing monooxygenase (FMO) and cytochrome P450 (CYP). Liver 
ADH catalyses the reversible transformation of alcohols to their corresponding 
aldehydes or ketones. ALDH enzymes oxidise a wide range of aldehydes to 
their corresponding carboxylic acids [105]. FMO oxygenates a wide range of 
xenobiotics that contain a nucleophilic heteroatom (usually sulphur and 
nitrogen, with the oxidative reaction resulting in the formation of N or S-
oxides), such as pesticides and drugs [58]. P450 enzymes usually catalyse 
monooxygenase reactions, which involve the insertion of an oxygen atom into 
a substrate [60]. 
Data were taken from the BRENDA enzyme database [57] and several reviews 
[26, 58-60]. Constants measured for mammals in in vitro assays of purified, 
non-recombinant, hepatic enzymes were selected. Data were available for 
different isoenzymes (i.e. any of the several forms of an enzyme, all of which 
catalyse the same reaction but are characterised by different properties) and 
for the following species: horse (ADH, ALDH), human (ADH, ALDH), rat (ADH, 
ALDH, CYP), mouse (FMO), pig (FMO) and rabbit (CYP). All data were checked 
in the original papers and are reported in the Appendix B (Table B1). 
Km values were expressed in μM and all rates were expressed as Vmax with 
μmol min-1 mgPROT
-1 as units. The rates were reported in the papers either as 
Vmax or as catalytic constant (kcat) values. The latter were transformed into Vmax 
using the weight of the enzyme or the content of microsomal protein (for CYP) 
as conversion factors. We used the values reported in the studies measuring 
kcat, when reported; otherwise, we used the average values obtained from 





Km and Vmax data were combined into 4 databases, one for each enzyme family, 
independently of the species and isoenzyme. Each substrate was characterised 
by a single value of 1/Km or Vmax. If multiple values were available for one 
substrate, we calculated the geometric mean and standard deviation of the 
experimental 1/Km or Vmax values. The compounds collected were represented 
as SMILES (simplified molecular input line entry system) strings. 
5.2.2 Molecular descriptors 
Approximately 2000 descriptors were calculated using the Online CHEmical 
Modeling environment platform (OCHEM) [91]. These descriptors included 
Mopac descriptors (version 7.1) [119], E-state indices (electro-topological state 
indices) [120], ALogPS [121], Adriana code (http://www.molecular-
networks.com), Chemaxon (http://www.chemaxon.com), CDK [122], 
Spectrophores (Silicos NV, http://openbabel.org) and a subset of Dragon 6 
(constitutional, topological and information indices, geometrical, charge, 3D-
MoRSE and GETAWAY descriptors, 2D autocorrelations, functional group 
counts, atom-centred fragments, molecular properties) [123]. 
5.2.3 Model development and validation 
First, the data of each dataset were split into a training set and a validation set 
in a 2:1 proportion [124]. For each training set, we calculated the correlation 
coefficient (R) of each descriptor with the experimental Log (1/Km) and Log Vmax 
values and filtered out descriptors with |R|<0.4. This procedure assures the 
stability and reliability of the models because only descriptors that have some 
correlation with the endpoint are considered. 
A Genetic Algorithm (GA) was then applied to the remaining descriptors with 
WEKA v.3.6.7 [125] to find the optimal subsets of variables that yielded models 
with the highest predictive powers [126]. The following parameters were set 
for the GA: 30 cycles, 400 children and 75 survivors. Because of the relatively 
small number of compounds in the datasets and to avoid overfitting, the 
number of variables to select was prefixed and limited to a maximum of 6 for 
ALDH, FMO and CYP, or four for ADH. The GA was optimised on multiple linear 
regression (MLR) and included a leave-one-out (LOO) validation procedure. 
With LOO cross validation, a single observation is removed from the original 
dataset, and the remaining observations are used as training data such that 
each observation is removed only once. A model is then developed for each 
reduced data set, and the response values of the removed observations are 
predicted from these models. The fitness function of the GA was the 
correlation coefficient for the LOO validation (QLOO): for each of the datasets, 
the subsets of one to six variables that provided the highest QLOO were 
selected. 
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The Akaike’s information criterion (AIC) was calculated to select which of the 
models with one to six variables was the most adequate to predict the Log Vmax 
and the Log (1/Km) of each enzyme. The AIC is a trade-off between a good fit to 
the model (measured by the likelihood) and a penalty for complexity 
(calculated using the number of parameters). The model with the lowest AIC is 
interpreted as the best model. The collinearity of the descriptors was checked 
using variance inflation factors (VIFs) calculated with the R package ‘car’ [127]. 
The threshold for collinearity was VIF>5 [128]. Therefore, for each dataset we 
selected the model with the lowest AIC and having all variables with VIFs<5. 
The models were first developed using the original values of the descriptors to 
obtain regression coefficients that can be used to estimate the Km and Vmax 
values for other chemicals. However, the descriptors are expressed in different 
units and scales, therefore those coefficients do not indicate the importance of 
each model parameter. To determine this importance, the predictors were 
scaled to zero-mean and unit-variance (auto-scaling) and used to calculate the 
standardised regression coefficients of the models. The values of the 
standardised coefficients allow for comparison of the contribution of each 
descriptor in influencing Km and Vmax. In addition, the predictors were classified 
into four general categories: 1) Functional group or fragment (E-state, 
functional group counts, etc.); 2) Size and shape (topological and geometrical 
descriptors); 3) Partitioning (logP); or 4) electronic parameters (descriptors 
related to electronic properties such as charge, polarizability, etc.). 
For every model, the coefficient of determination (R2) and the Root Mean 
Squared Error (RMSE) were calculated as measures of model fit. The 
applicability domains of the QSARs, required by the OECD QSAR validation 
principles [64], are defined by the range (min and max) of the values of the 
descriptors used to build the model [104]. 
The MLR models developed using the training sets were validated with the 
WEKA data mining software using two procedures: leave-one-out (LOO) cross 
validation and external cross validation with the validation set. The predictive 
ability of the models was quantified using the R2 and the RMSE for the LOO 
cross-validation (Q2LOO and RMSELOO) and for the external validation (R
2
EXT and 
RMSEEXT). The equations used to calculate the statistical parameters are 
reported in Appendix B. 
 
5.3 Results 
For every enzyme, the QSAR models selected for Log (1/Km) and Log Vmax and 
their statistical parameters are provided in Tables 5.1 and 5.3, respectively. 





and their categories with brief explanations when necessary. In the equations 
of the QSARs, the variables are reported in order of relative importance from 
highest to lowest. Figure 5.1 shows the values of the standardised regression 
coefficients of the predictors selected for A) Log (1/Km) and B) Log Vmax. Figures 
5.2 and 5.3 compare the measured values to the values predicted by the 
QSARs for Log (1/Km) and Log Vmax, respectively. The applicability domains of 
the QSARs are provided in Tables E1 and E2 of Appendix E for Log (1/Km) and 
Log Vmax, respectively. 
5.3.1 Log (1/Km) 
The models for Log (1/Km) had explained variances (R
2
adj) and leave-one-out 
cross-validated explained variances (Q2LOO) of approximately 50% for CYP and 
FMO, 70% for ALDH and 80% for ADH (Table 5.1). The predictive abilities of the 
models (R2ext) were approximately 50% for CYP and FMO and 60% for ADH and 
ALDH (Table 5.1). For ADH, the number of aliphatic secondary alcohols (nOHs, 
Dragon 6) was the most important descriptor (i.e. the one with the highest 
standardised correlation coefficient, negative in this case). The most influential 
descriptor for ALDH was the Adriana 3D autocorrelation descriptor 
3DACorr_PiChg_2 with a positive coefficient. For FMO, the most important 
descriptor was RHSA, a CDK descriptor combining surface area and partial 
charge information, which was positively correlated with Log (1/Km). For CYP, 
the most important descriptor was the aromaticity index AROM (Dragon 6) 
with a negative coefficient. 
5.3.2 Log Vmax 
The best models for Log Vmax had explained variances (R
2
adj) and leave-one-out 
cross-validated explained variances (Q2LOO) varying from approximately 20% for 
FMO to approximately 80% for ADH (Table 5.3). The explained variances were 
approximately 50% and 60% for ALDH and CYP, respectively. The predictive 
abilities of the models (R2ext) were approximately 30% for FMO, 50% for CYP 
and ALDH and 60% for ADH (Table 5.3). For ADH and ALDH, the most 
important descriptors were the functional group counts nHDon and nArX 
(Dragon 6), respectively, which were both negatively correlated with Log Vmax. 
These descriptors indicate the number of donor atoms for hydrogen bonds 
(nHDon) and the number of halogens on an aromatic ring (nArX). For FMO and 
CYP, the most influential descriptors were the E-state indices Se1C3N3as and 
Se1C1C3sd, with a positive and a negative coefficient, respectively. 
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Figure 5.1. Standardised regression coefficients of the predictors in the QSARs 
for (A) Log (1/Km) and (B) Log Vmax for the four enzyme classes (ADH, ALDH, 
FMO and CYP). The standardised coefficients were obtained by using the 
descriptors scaled to zero-mean and unit-variance. The predictors were 
classified in four categories: 1) Functional group or fragment; 2) Size and 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5.4.1 Model limitations 
Because the experimental Km values and rates were collected from the 
scientific literature, they come from different laboratories often employing 
different protocols, e.g. conditions of pH and temperature, which can affect 
enzyme activity [78]. In addition, the rates were reported in the papers either 
as Vmax or kcat values. The latter were transformed into Vmax (Appendix B, Table 
B2) using the weight of the enzyme or the content of microsomal protein (for 
CYP) as conversion factors. For the conversion factors, we used the values 
reported in the studies measuring kcat, when available; otherwise, we used the 
average values from other studies. Consequently, part of the residual error is 
likely caused by these different sources of variation in the input data (i.e. 
experimental variation and inaccuracies in conversions). Furthermore, we 
merged data measured for different mammalian species (i.e. human, horse, 
rat, mouse, pig and rabbit) and isoenzymes (i.e. any of the several forms of an 
enzyme, all of which catalyse the same reaction but are characterised by 
different properties). The merging process is likely another source of 
unexplained variation. Finally, when using a QSAR to predict the Km or Vmax 
value of a new compound, it is important to know whether the chemical is a 
putative substrate for the enzyme. 
The QSARs developed for CYP in the present work yielded lower R2 values than 
the QSARs obtained in other studies with R2 values of approximately 0.8-0.9 
[26, 27]. However, the latter datasets typically included homologous series of 
approximately 10 structurally related compounds metabolised by one given 
isoenzyme in one mammalian species. Thus, those models are only applicable 
to specific combinations of compounds, isoenzymes and species for which a 
similar behaviour can be anticipated. Cronin et al. [67] argued that an R2 value 
between 0.6 and 0.7 is all that can realistically be expected for heterogeneous 
datasets such as the ones used in the present study. 
For a model with good external predictability, R2ext values should be higher 
than 0.5, and the difference between R2 and R2ext should be no larger than 0.2-
0.3 [129]. This result was the case for all models except for the Vmax of FMO. 
The low explained variance for the Vmax of FMO is likely because of an unusual 
feature of its catalytic cycle, in which substrate binding has no effect on 
velocity [58]. The rate-limiting step of the FMO catalytic cycle depends on one 
of two initial enzyme reactions, i.e. either the reaction of the FAD prosthetic 
group with NADPH or its successive reaction with molecular oxygen. These two 
steps generate the enzyme-bound flavin-hydroperoxide (FADOOH) that is 
required before binding and responsible for the oxidation of suitable 





limiting step for the overall reaction rate occurs before substrate oxidation, 
Vmax is independent of chemical properties. Consequently, the Vmax values of 
FMO are generally similar across different chemicals, whereas the Km values 
may vary [130]. In this study, Vmax values covered less than two orders of 
magnitude (-1.3<Log Vmax<0.4, Fig. 5.3C and Table E2 in the Appendix E). 
5.4.2 Model interpretation 
Log (1/Km) 
The importance of the properties influencing 1/Km appeared to be specific to 
the enzyme group considered. Functional groups or fragments were the most 
relevant predictors for the enzyme groups metabolising specific compounds, 
i.e. ADH, ALDH and FMO, which have substrates that are mainly alcohols, 
aldehydes and chemicals with a nucleophilic heteroatom, respectively. These 
predictors provide information on the chemical features that drive substrate 
binding. For ADH, the most influential descriptor nOHs (Dragon 6) indicates the 
number of aliphatic secondary alcohols (R-CH-OH-R) that are metabolised into 
ketones by ADH. The binding affinity is lower for secondary alcohols, as shown 
by the negative regression coefficient of nOHs, possibly because the OH group 
on the secondary carbon disfavours the hydrophobic interaction between the 
alkyl groups of the substrates and the active site of ADH enzymes. For ALDH, 
the most important descriptor 3DACorr_PiChg_2 (Adriana) was positively 
correlated (R>0.85) with the number of nitrogen groups in an aromatic 
molecule (nArNO2, Dragon 6). Log (1/Km) values are higher for aromatic 
aldehydes (positive regression coefficient), which are usually also more 
hydrophobic. Functional groups or fragments were particularly relevant for Log 
(1/Km) of FMO (four of the six selected descriptors). The E-state index 
Se1N1N2ss and the Dragon 6 descriptor N-067 refer to nitro groups. These 
fragments represent single bonds between two N atoms (NH2-NH) and the 
number of fragments containing secondary aliphatic amines, respectively. FMO 
substrates are typically soft nucleophiles, i.e. compounds with functional 
groups bearing a polarizable, electron-rich centre that is usually a heteroatom 
(such as nitrogen, sulphur and phosphorus) in organic compounds [58]. The 
descriptor 2DACorr_LpEN_1 (Adriana) was highly related (R>0.9) to the 
number of heteroatoms (nHet, Dragon 6). The positive coefficient shows that 
the higher the number of heteroatoms in the molecule, the higher the chances 
for the substrate to bind to FMO are, consistent with FMO catalytic cycle. The 
hydrophilic factor (Hy, Dragon 6) describes the hydrogen-bond donor ability of 
the molecules. This predictor is related to the presence of hydrophilic groups in 
the molecule, which comprise hydrogen attached to an electronegative 
heteroatom (-OH, -SH, -NH). The 1/Km increases with the hydrogen-bond donor 
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ability, suggesting the importance of hydrogen bonding in the interactions of 
the molecule with the binding site of the enzyme. 
In all QSARs for Log (1/Km) except for FMO, the majority of the predictors were 
associated with partitioning or the size and shape of the substrates. These 
descriptors indicate the importance of weak, non-specific interactions 
between substrate and binding site of these enzymes, e.g. via desolvation 
processes, consistent with previous work [30, 79]. In particular, for CYP 
enzymes, four of five predictors were related to the geometry of the 
molecules, likely because of the broad substrate specificity of these enzymes, 
which can bind to and oxidise many structurally diverse compounds. In fact, 
any electron-donating substrate that is properly positioned can gain access to 
the CYP active site [131]. In the Log (1/Km) QSAR for CYP, the predictors AROM 
(Dragon 6) and C2SP3 (CDK) represent the aromaticity index and the number 
of single bound carbon atoms bound to two other carbon atoms, respectively. 
Aromatic molecules comprise planar rings of sp2 hybridized atoms with a cyclic 
electron delocalisation that makes these compounds stable [132]. These two 
predictors are related to the number of aromatic atoms, which describes a 
hydrophobic feature of the molecules and was positively correlated with 1/Km. 
The packing density index (PDI) is a molecular property defined as the ratio 
between the McGowan volume and the total surface area. The positive 
correlation coefficient of PDI shows that binding increases with substrate size 
for CYP enzymes. The molecular surface area featured in the QSAR for ALDH 
(Mor01, Dragon 6) was positively correlated with 1/Km. A larger molecular size 
increases the possibility of interactions with the binding site and the 
hydrophobic nature of the molecules. The descriptors for partitioning are 
Mor23u (Dragon 6) for ADH and XLogP for ALDH. The latter is the octanol-
water partitioning coefficient (logP) predicted using the XLogP atom-type 
method (CDK) and had a positive regression coefficient. Mor23u (Dragon 6) 
was negatively correlated with logP (Dragon 6) for the compounds in the 
training set (R<-0.9). For ADH and ALDH, 1/Km increased with increasing 
hydrophobicity of the substrates, confirming the hydrophobic nature of the 
binding site of these enzymes. 
The electronic parameters were relevant for FMO and, to a lesser extent, for 
CYP. This result indicates that for these enzymes 1/Km describes strong 
interactions with substrates, such as polar bonds, which can be understood 
from their catalytic cycles [117]. The catalytic mechanism of FMO involves a 
nucleophilic attack that occurs before binding [58]. CYP enzymes have a 
catalytic mechanism with many steps occurring between binding and substrate 
oxygenation [49]. Km values may be sensitive to kinetic perturbations at 
catalytic steps occurring after substrate binding; thus, 1/Km values may not be 





autocorrelation descriptor JGI5 belongs to the Galvez topological charge 
indices, which evaluate the charge transfers between pairs of atoms and the 
global charge transfers in the molecule [133]. For FMO, the most important 
descriptor RHSA (CDK) is a combination of surface area and partial charge. 
RHSA was positively correlated with 1/Km as polar interactions increase with 
increasing solvent accessible area occupied by partial charges. Another 
descriptor of electronic properties for FMO was R4e+, which is a GETAWAY 
Dragon descriptor weighted by Sanderson electronegativity (e). This result 
confirms the importance of partial charges in the interaction of substrates with 
FMO enzymes. 
Log Vmax 
The “functional groups or fragments” descriptors were particularly important 
for Log Vmax. For Log Vmax of ADH, the most influential descriptors nHDon 
(Dragon 6) and tautomercount (Chemaxon) indicate the number of donor 
atoms for hydrogen bonds (i.e. the count of N and O atoms) and the number of 
tautomers (i.e. isomers that have the same molecular formula but switching 
single bond and adjacent double bond), respectively. The Vmax tends to be 
higher for chemicals with a lower hydrogen-bond donor ability, which 
correspond to the aldehydes in the ADH dataset. The number of tautomers is 
also a fragment that is linked to aldehydes. This descriptor was highly 
correlated (R>0.9) with Se1C2C2sd, an E-state index representing a single bond 
(e1) between an sp2 C and an sp3 C (X=C-C-R). For the compounds in the 
dataset, this bond was found in the aldehyde fragments (R-C=O), and its 
positive regression coefficient again indicates that aldehydes yield higher Vmax 
values. In fact, ADH enzymes metabolise also aldehydes to alcohols at a rate 
that is higher than the one of the opposite reaction (from alcohols to 
aldehydes). For ALDH, the most important predictor nArX (Dragon 6) 
represents the number of halogens (X = Cl, Br, I, F) on an aromatic ring. The 
compounds that have this fragment are characterised by a low Log Vmax, as 
shown by the negative regression coefficient of nArX. Notably, these 
compounds are halogenated benzaldehydes, compounds that were outliers for 
the Log (1/Km) regressions with Log Kow in our previous work [79]. This result 
can be expected because compounds containing more halogens (particularly Cl 
and F) are usually more stable. For CYP, the most important predictor 
Se1C1C3sd describes a single bond between two C atoms (RC(=X)-C). This 
descriptor was highly correlated (R>0.9) with the Dragon 6 descriptor H-051, 
which represents the number of H atoms attached to alpha C (i.e. the C atom 
bonded to a functional group). The negative sign of the regression coefficient 
shows that a lower number of H atoms attached to alpha C increases the 
velocity of the reaction. The alpha C is an active atom and tends to lose acidic 
protons, thus affecting the reactivity of the substrates [134]. For FMO, all 
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descriptors selected for Log Vmax were E-state indices. Se1C3N3as indicates 
tertiary amines (N3). The presence of this fragment increases the Vmax (positive 
regression coefficient), suggesting that the nucleophilic attack is favoured on 
this nitrogen. Se2C3O1s represents the carbonyl group (R’(R)C=O); in the FMO 
dataset, this fragment recurs in amides (R’-NC(=O)-R) and carbamate 
pesticides (R’-NC(=O)O-R). The negative regression coefficient suggests that 
the presence of the carbonyl group in the molecule lowers its maximum 
velocity. Because the statistics for the Log Vmax QSAR for FMO were not 
satisfactory, these descriptors can be considered only an indication of the 
involvement of nitrogen in substrates metabolised by FMO. 
Electronic properties of the substrates also played an important role in the 
QSARs for Log Vmax. Interactions characterised by the cleavage and formation 
of covalent or ionic bonds are described by electronic properties of the 
substrates. For all enzymes except FMO, at least one Dragon 6 3D-MoRSE 
descriptor (3D-Molecule Representation of Structures based on Electron 
diffraction) was selected. MoRSE descriptors yield good modelling power for 
different biological and physicochemical properties because they 
simultaneously consider the 3D structure and various atomic properties [135]. 
Polarity was relevant for the Vmax of CYP substrates, as indicated by the 
descriptor formalcharge_pH_7.4 (Chemaxon). Previous studies on P450 
enzymes have also demonstrated that Vmax depends on electronic properties 
[29]. At the CYP active site, the oxidation of chemicals is performed by an 
electron-deficient complex (FeO3
+), which abstracts either a hydrogen atom or 
an electron from the substrate [49]. Therefore, strong interactions are involved 
in the maximum velocity of these enzymes. 
For Log Vmax, only a few descriptors related to the size and shape of the 
molecules were featured in the QSARs. Furthermore, their occurrences were 
limited to the models for ADH and ALDH. For ADH, ASP (molecular asphericity) 
describes the shape of molecules; it varies from zero for totally spherical 
molecules to unity for flat molecules, such as benzene. The positive regression 
coefficient shows that flat molecules are characterised by higher values of Log 
Vmax, likely because more reactive sites are accessible to the metabolising 
enzymes. For ALDH, the geometry predictor R6m+ (Dragon 6) belongs to 
GETAWAY (GEometry, Topology and Atom-Weights AssemblY) descriptors 
weighted by atomic mass. These descriptors are based on spatial 
autocorrelation formulae that incorporate 3D information and weight the 
molecule atoms by different properties, such as mass, polarizability and 
volume [135]. The small role played by geometric factors in determining Vmax 
compared with fragments and electronic properties is because of the nature of 
enzymatic catalysis. Metabolic reactions are characterised by bond cleavage 





functional groups or fragments can capture the features of the substrates that 




The importance of the properties influencing the affinity constant (1/Km) 
appeared to be specific to the enzyme group considered. Functional groups or 
fragments were the most relevant predictors for the enzyme groups 
metabolising specific compounds, i.e. ADH, ALDH and FMO. Size and shape 
properties were also important for binding, especially for CYP enzymes, likely 
because of the broad substrate specificity of CYP enzymes. These descriptors 
indicate weak non-specific interactions between the substrates and binding 
sites of these enzymes, e.g. via desolvation processes. Electronic factors and 
functional groups or fragments were particularly important for the maximum 
reaction rate Vmax. This constant represents the catalytic process, which 
involves specific interactions between substrate and enzyme, characterised by 
the cleavage and formation of covalent bonds. The present study can be 
helpful to predict the Km and Vmax of four important oxidising enzymes in 
mammals and better understand the underlying principles of chemical 
transformation by liver enzymes. 
 
Appendices 
Appendix B contains the datasets collected for this study, as well the formulas 
of the statistical parameters used to assess model fitting and predictivity. 
Appendix E contains the applicability domains of the QSAR models. 
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Biotransformation is one of the processes that can influence the 
bioaccumulation of compounds in organisms [136]. Through 
biotransformation, the parent compound is converted via enzymatic reactions 
into another chemical (metabolite), which is usually more soluble and thus can 
be excreted more easily [1]. The biotransformation potential of xenobiotics is 
often assessed using data from in vitro metabolic tests [19, 137, 138]. Since 
liver is the principal organ responsible for metabolism in fish and mammals, in 
vitro assays are mostly performed with preparations from hepatic tissue, such 
as isolated hepatocytes, S9 liver fractions, or liver microsomes [22, 139, 140]. 
The xenobiotics are incubated with these liver preparations, which contain 
different complements of metabolising enzymes, to obtain the in vitro intrinsic 
clearance (CLINT). For reactions that exhibit classical Michaelis-Menten kinetics 
and at non-saturating substrate concentrations, the in vitro CLINT is defined as 
the ratio between the maximum velocity of the reaction (Vmax) and the 
Michaelis constant (Km), which is the substrate concentration at half Vmax [19]. 
The in vitro CLINT values can be extrapolated to estimate whole-body in vivo 
biotransformation rates, thus they can be of crucial importance for the risk 
assessment of xenobiotics [19, 138]. 
Measured in vitro CLINT data are available only for a limited number of 
chemicals and species, and models can be useful to predict the CLINT for 
chemicals that have not been tested yet. Quantitative structure-activity 
relationships (QSARs) are models correlating structural, physical and chemical 
properties of substances with their biological activity by means of statistical 
approaches [10]. QSARs are based on the assumption that compounds with 
similar structural features will have similar biological activities and/or 
physicochemical properties. The models built on experimental data can then 
be used to predict the biological activity of a broader range of related 
chemicals. Other advantages of QSARs, beyond prediction, include identifying 
influential structural and/or physicochemical characteristics or gaining insights 
into the mechanism of action for the process investigated [10]. Models have 
been built to predict enzyme-specific Km and Vmax of various xenobiotics 
metabolised by oxidising enzymes in mammals [141]. These QSARs are 
important to predict and to understand the enzymatic processes underlying 
specific metabolic pathways. It is, however, often difficult to know beforehand 
which metabolic pathway(s) a substance will undergo. For this reason, 
clearance measured in liver preparations containing different complements of 
enzymes, such as microsomes and hepatocytes, provide a more accurate 
measurement of the overall metabolic activity. QSARs have been developed to 
predict clearance in microsomes or hepatocytes of mammals [33-36] using 
information on the chemical structure. Nevertheless, these models included 
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only pharmaceuticals, with the aim to accelerate the selection of new 
candidates in the drug discovery stage based on their predicted clearance. To 
our knowledge, no QSARs have yet been developed to predict in vitro CLINT 
including environmental pollutants in the training set. 
The aim of this study was to develop QSARs for in vitro clearance in humans 
measured in hepatocytes and microsomes. The QSAR models were based on 
datasets of 118 compounds (of which 53 environmental pollutants) for 
hepatocytes and 115 compounds (of which 56 environmental pollutants) for 
microsomes. The models were built with multiple linear regressions (MLR) by 
selecting theoretical descriptors and were mechanistically interpreted to 
provide insight into the processes governing biotransformation. External 
validation was applied to assess the predictive power of the models [64]. 
 
6.2 Materials and Methods 
6.2.1 Experimental dataset 
Clearance data (CLINT) for humans were collected from the scientific literature 
for the two most commonly used in vitro metabolism assays: isolated 
hepatocytes and liver microsomes [142]. Liver microsomes are subcellular 
fractions (endoplasmatic reticulum) with relatively high concentrations of 
phase I drug-metabolising enzymes, especially cytochrome P450 (CYP) [143]. 
Isolated hepatocytes are liver cells, thus they contain the full complement of 
phase I and phase II metabolic enzymes and essential cofactors (e.g. NADPH). 
Phase I enzymes metabolise most of the xenobiotics, so microsomes are often 
used to assess metabolism as they are convenient to prepare for many species. 
Nevertheless, predictions of in vivo CLINT from hepatocytes data are usually 
more accurate than those from microsomal data [144], since all possible 
metabolic reactions can take place in hepatocytes and most transporter 
functions are preserved, mimicking the in vivo systems [143]. Clearance can be 
measured either by the decrease in the amount of the parent compound 
(substrate depletion) or by an increase in the metabolites (product formation) 
[22]. The first method allows for a more precise quantification of the 
clearance, but data obtained with both methods were used in the present 
study in order to obtain larger datasets. 
For hepatocytes, the measured CLINT values were taken from Tonnelier et al. 
[145], who gathered human liver metabolism data for 94 chemicals, mainly 
pesticides and drugs. Additional data were taken from Sohlenius-Sternbeck et 
al. 2010 [146], who measured CLINT values for 52 pharmaceuticals in human 
hepatocytes. All CLINT data collected (units: µL/min/10
6 cells) were derived 





retained, i.e. different from zero and above the limit of the detection. When 
more than one CLINT value was available for one compound, the geometric 
mean of the CLINT values was used in the dataset. The CLINT values for human 
hepatocytes are reported in Table F1 (Appendix F), for a total of 119 
compounds. 
For liver microsomes, the measured CLINT values were collected from individual 
studies published in scientific literature. We used the following search terms in 
the Pubchem and Google Scholar search engines (last access on 7 November 
2014): 1) liver, human in vitro, microsomes, and 2) intrinsic clearance, Vmax, Km, 
Michaelis-Menten, first-order, rate constant, kinetic constant, kinetic rate. We 
checked all papers resulting from this search (approximately 6,000), together 
with all of the citing and cited papers. Among these papers, we retained only 
those reporting experiments conducted in human liver microsomes at 
physiological conditions, i.e. pH 7.4 and T 37°C. All data were expressed as CLINT 
(units: µL/min/mgMICR); if data were reported as Km and Vmax, CLINT was 
calculated as the ratio Vmax/Km. The majority of the data for environmental 
pollutants (more than 90%) was measured following product formation, while 
for pharmaceuticals clearances were all determined following substrate 
depletion. For the experiments following product formation, if more than one 
main metabolite was detected, the clearance of the parent compound was 
calculated as the sum of the clearance values measured for each product. 
When more than one CLINT value was available for one compound, the 
geometric mean of the CLINT values was used in the dataset. The CLINT values 
for human liver microsomes are reported in Table F2 (Appendix F), for a total 
of 115 compounds. 
6.2.2 Molecular descriptors 
The datasets were uploaded to the Online CHEmical Modeling environment 
platform [91] (OCHEM, http://ochem.eu) and the chemical structures were 
visualised to check if they were correct. In addition, the nitro groups on the 
molecules were standardised to N(=O)=O [147, 148]. Approximately 2200 
descriptors were calculated using the OCHEM platform, including 
1. E-state indices [149], which combine electronic and topological information 
about a molecule and allow identification of the relevant structural fragments 
governing the activity of chemicals. 
2. The octanol/water partition coefficient (LogP) and solubility in water (LogS) 
with the ALOGPS 2.1 program [121]. 
3. Chemaxon descriptors at pH 7.4 [150], including elemental analysis (e.g. 
mass, atom count, etc.), charge, geometry (e.g. polar surface area, volume, 
etc.), partitioning (i.e. LogD7.4), acceptor and donor counts, etc. 
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4. MOPAC descriptors [119] (version 7.1): MOPAC is a semi-empirical 
molecular orbital package which allows the calculation of quantum chemical 
descriptors such as HOMO and LUMO energies, electronic energy, etc. 
5. DRAGON descriptors [132] (version 6), including only constitutional (mass, 
atom and bound counts, etc.), topological and geometrical descriptors, 
connectivity indices, functional group counts, atom-centred fragments, charge 
descriptors and molecular properties. 
6. Adriana code (http://www.molecular-networks.com), including 
physicochemical, 2D, 3D and surface-based molecular descriptors and 
properties. 
7. CDK [122], including constitutional (atom and bound counts) and topological 
descriptors. 
One substance (abamectin) was omitted from the hepatocytes dataset 
because not all molecular descriptors could be calculated. This was due to the 
fact that the CDK package was unable to process this big molecule. 
6.2.3 Model development and validation 
The QSAR models were developed following the same steps both for 
hepatocytes (118 compounds) and microsomes data (115 compounds). Before 
developing the QSARs, the CLINT value of each chemical was Log transformed in 
order to normalise the data [35]. For each dataset, the data were split into a 
training set and a test set in a 2:1 proportion [124]. Chemicals were ordered 
according to decreasing values of clearance and separated into triplets. From 
each of the triplets, one chemical was inserted in the test set (33% of the 
compounds): for the hepatocytes, it was the second compound of each triplet 
and for the microsomes it was the third one. The compounds in each training 
set were used to build the QSAR, which was applied to the compounds in the 
test set to estimate the predictive power of the model. 
For each training set, ten descriptors were selected. A common forward 
selection was implemented for the prioritisation of the most relevant 
combination of descriptors with the p-value (derived from a general linear 
regression model) as the decisive criterion whether to include the descriptor. 
General linear models (GLM) were developed with the software R v.3.03 [95]. 
The R package ‘bestglm’ [96] was used to select the best subset among the 10 
descriptors after an exhaustive search. In order to avoid overfitting, the 
maximum number of variables to be included in the subsets was set at 6 [97]. 
The collinearity of the variables was checked using variance inflation factors 
(VIFs), calculated with the R package ‘car’ [127]. If all variables had VIFs<5 





The models were first developed using the original values of the descriptors to 
obtain regression coefficients that can be used to estimate the in vitro CLINT 
values for other chemicals. However, the descriptors are expressed in different 
units and scales, therefore the resulting coefficients do not indicate the 
importance of each model parameter. To determine this importance, the 
predictors were scaled to zero-mean and unit-variance (auto-scaling) and used 
to calculate the standardised regression coefficients of the models. The values 
of the standardised coefficients allow for comparison of the contribution of 
each descriptor in influencing CLINT. In order to facilitate the interpretation of 
the models, the predictors were classified into four general categories: (1) 
functional group or fragment (E-state, functional group counts, etc.); (2) size 
and shape (topological and geometrical descriptors); (3) partitioning (Log P, 
LogD7.4); or (4) electronic parameters (descriptors related to electronic 
properties such as charge, polarizability, etc.). 
The fitting ability of the QSARs was evaluated using a range of statistical 
parameters, i.e. the coefficient of determination (R2), the adjusted R2 (R2adj), 
the Root Mean Squared Error (RMSE) and the p-value from the F-test (p). The 
applicability domains of the QSARs, required by the QSAR validation principles 
established by the Organisation for Economic Co-operation and Development 
(OECD) [64], were defined by the range (min and max) of the values of the 
descriptors used to build the model [104]. The models built using the training 
sets were validated with WEKA using two procedures: internal validation of the 
models with the leave-one-out (LOO) procedure and external cross-validation 
of the models with the test set. The LOO cross-validated R2 (Q2LOO) and RMSE 
(RMSELOO) were calculated to assess the internal predictivity of the models and 
the external predictivity was expressed with the external coefficient of 
determination (R2ext) and RMSE (RMSEext). The equations used to calculate the 
statistical parameters are reported in Appendix B. 
 
6.3 Results 
The resulting QSAR models for hepatocytes and microsomes are reported in 
Table 6.1, together with their statistical parameters. Table 6.2 contains the 
definitions of the descriptors used in the QSARs and their categories. In the 
equations of the QSARs, the variables are reported in order of relative 
importance from highest to lowest standardised regression coefficients. Figure 
6.1 shows the values of the standardised regression coefficients of the 
predictors selected for CLINT. Figure 6.2 compares the measured Log CLINT 
values to the values predicted by the QSARs for A) human hepatocytes and B) 
human microsomes. The applicability domains of the QSARs are provided in 
Table F3 of Appendix F. 
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Significant correlations (p < 0.01) were obtained for both the hepatocytes and 
microsomes QSARs (Table 6.1), with explained variances (R2adj) of 67% and 
50%, respectively. The leave-one-out cross-validated explained variances 
(Q2LOO) and the predictive abilities of the models (R
2
ext) were approximately 
60% for hepatocytes and 30% for microsomes (Table 6.1). The most important 
variables were R5e+ for hepatocytes and HATS5e for microsomes, both with a 
negative regression coefficient. These are Dragon 6 GETAWAY descriptors 
weighted by Sanderson electronegativity, thus related to electronic properties. 
The other descriptors selected for hepatocytes were the Dragon6 GETAWAY 
HATS0m and R8u+, associated to fragments and geometry respectively, and 
the Adriana 2D autocorrelation descriptors 2DACorr_SigChg_2 and 
2DACorr_SigChg_5 weighted by σ atom charges, thus related to electronic 
properties. The other descriptors selected for microsomes were the E-state 
indices Se2C2O1s and Se2O1P4s associated to fragments, the Dragon6 
GETAWAY descriptor GATS4v associated to size, the Adriana 2D 
autocorrelation descriptor 2DACorr_SigChg_9 weighted by σ atom charges and 
the Chemaxon geometry descriptor SmallestRingSize. 
Figure 6.1. Standardised regression coefficients of the predictors in the QSARs 
for Log CLINT for human hepatocytes and microsomes. The standardised 
coefficients were obtained by using the descriptors scaled to zero-mean and 
unit-variance. The predictors were classified in four categories: (1) Functional 
group or fragment; (2) Size and shape; (3) Partitioning (no descriptors 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6.4.1 Model limitations 
In this study, in vitro clearance data measured in human hepatocytes and 
microsomes for pharmaceuticals and environmental chemicals were collected 
from literature. We used the data collected to build QSARs to predict in vitro 
clearance for a broader set of related chemicals using theoretical molecular 
descriptors. To our knowledge, this is the first attempt to predict this endpoint 
for such a diverse set of chemicals. The QSAR models were validated for 
predictivity (both internal and external) and an applicability domain was 
provided (Table F3 in Appendix F). 
Because the experimental CLINT values and rates were collected from individual 
papers, they come from different laboratories often employing different 
protocols and this can affect enzyme activity [78]. In addition, the rates were 
measured following substrate depletion in some cases and product formation 
in others. The QSARs developed for CLINT in the present work yielded lower 
explained variances than the QSARs obtained in other models for hepatocytes 
[34-36], listed in Table 6.3, with R2 of approximately 0.8-0.9 and R2ext of 0.7-0.8. 
However, the previous QSARs were built with small datasets of 18 up to 71 
pharmaceuticals and either included a large amount of descriptors compared 
to a small number of compounds in the training set (potential over-fitting), as 
was the case for [35] and [36], or used CLINT values measured under 
standardised laboratory conditions, as was the case for the 18 compounds in 
[34]. Cronin et al. [67] argued that an R2 value between 0.6 and 0.7 is all that 
can realistically be expected for heterogeneous datasets such as the ones used 
in the present study. For a model with good external predictability, R2ext values 
should be higher than 0.5, and the difference between R2 and R2ext should be 
no larger than 0.2-0.3 [129]. This was the case for the hepatocytes model, 
whereas the microsomes QSAR had lower explained variance (R2adj 50% vs. 
67% and R2ext 30% vs. 62%, Table 6.1). This may be because the data set for 
microsomes was more heterogeneous. For microsomes, data were obtained 
from different studies (almost one study per compound, implying a large 
experimental variability), while the data for hepatocytes are from standardised 






Table 6.3. Summary of QSARs models presented in literature to predict in vitro 
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 = 0.91; RMSE = 
0.24, R
2
ext = 0.65 
ANN = Artificial Neural Networks; MLR = Multiple Linear Regression 
6.4.2 Model interpretation 
The intrinsic clearance in human liver microsomes and hepatocytes is a 
composite rate determined by various factors: chemical-specific uptake 
kinetics (either by transporters or by passive diffusion), chemical-specific 
association-dissociation kinetics with the metabolising enzymes, the actual 
chemical reaction rate and the ‘free’ or unbound chemical fraction available to 
interact with the enzymes [143]. In addition, the metabolic rate is influenced 
by the enzyme composition in the in vitro assay, i.e. both concentration of 
individual enzymes and which enzymes are present. In fact, chemicals can be 
metabolised by more than one enzyme, each with different specialities and 
reaction characteristics, and it is difficult to know beforehand which metabolic 
pathway they will undergo. Therefore, in the interpretation of the QSARs all 
these factors need to be considered. 
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In both QSARs, electronic properties of the substrates played a dominant role 
in predicting the clearance, while partitioning properties were absent (Figure 
6.1). This may suggest that processes usually influenced by weak interactions 
(such as passive uptake for hepatocytes and enzyme binding) are not rate-
limiting. Interactions characterised by the cleavage and formation of covalent 
or ionic bonds are described by electronic properties of the substrates. Thus, 
partial charges are important in the catalytic reaction between substrate and 
enzyme, as also noted in previous QSARs for clearance of drugs in hepatocytes 
(Table 6.3) [34-36]. All electronic descriptors, except 2DACorr_SigChg_9, are 
negatively related to metabolic clearance, i.e. an increased value of the 
descriptors will decrease the clearance. It is difficult to give a mechanistic 
explanation based on such composite, largely mathematical autocorrelation 
descriptors combining structural and electronic characteristics of the molecule, 
but some observations can be made. For example, R5e+ and HATS5e are 
autocorrelation descriptors of lag 5, with lag being the topological distance. 
This means that only those atoms that are exactly 5 path lengths separated are 
included to calculate the values for these descriptors. Larger molecules would 
typically have more of these atoms, whereas small molecules would have less 
or none of these atoms. So, larger molecules would likely have a higher score 
on R5e+ and HATS5e. These two descriptors are weighted by the 
electronegativity, and their negative regression coefficient indicates that a 
higher electronegativity would result in a higher clearance. Molecules having 
more atoms with a high electron density, thus more reactive centres, will 
probably have higher metabolic rates. In combination with the size 
characterisation described above, this suggests that small molecules with 
many partially charged atoms are more easily metabolised than large 
molecules with less reactive centres. 
Functional groups or fragments were also relevant for the clearances in both 
hepatocytes and microsomes (Figure 6.1) and were useful to identify specific 
compounds having a deviating clearance compared to the others in the 
datasets. For hepatocytes, the GETAWAY Dragon 6 descriptor is highly 
correlated (R>0.9) to the E-state index Se1C3Cl1a indicating a single bond 
between a carbon atom in an aromatic ring and a chlorine atom. The presence 
of chlorine substituents in an aromatic ring lowers the clearance (negative 
regression coefficient), similarly to what happens for bacterial biodegradation. 
In fact, the resistance of chlorinated aromatic compounds to biodegradation 
generally increases with the degree of chlorination [151]. In the hepatocytes 
dataset, the E-state Se1C3Cl1a is indicative of polychlorinated biphenyls 
(PCBs), which have much lower clearance values than the other compounds 
(Figure 6.2A). In the microsome dataset, only one compound belongs to the 





PCBs are persistent pollutants, having high intrinsic elimination half-lives in 
humans of approximately 10–15 years [152]. For microsomes, two molecular 
bond E-state indexes were selected: Se2C2O1s and Se2O1P4s. The E-state 
index Se2C2O1s corresponds to a double bond between an oxygen and a 
carbon atom bound to a substituent group and to a hydrogen atom 
(O=CH(R1)). In our QSARs, compounds with this group are organic amides 
(O=CH-N(R1)R2)) which have low clearance values (negative regression 
coefficient). Two of these compounds have the lowest observed clearance 
values in the microsome dataset (Figure 6.2B), and all three of them have the 
lowest predicted Log CLINT values. The E-state index Se2O1P4s corresponds to a 
double bond between an oxygen and a pentavalent phosphorous atom (O=P≤). 
In our datasets, the only compound with this bond is the pesticide profenofos, 
which is a phosphorothiolate pesticide (O=P-S-C) and has the highest clearance 
value among all the compounds metabolised by human microsomes (Figure 
6.2B). This is not surprising as organophosphates are known to be 
metabolically instable, in fact they displaced persistent pesticides as DDT [153]. 
Few geometry descriptors featured in the QSARs for metabolic clearance 
(Figure 6.1). The Chemaxon descriptor SmallestRingSize selected for 
microsomes represents the number of atoms forming the smallest ring in the 
compound. This descriptor has a negative regression coefficient, which 
indicates that compounds with larger rings are less easily metabolised and 
compounds without rings have higher clearances. A lack of rings generally 
increases the flexibility of chemicals [132]. Linear chemicals may thus better 
adjust to the active site of the enzyme and be more easily metabolised. In 
previous QSARs for clearance of drugs in hepatocytes, the shape and size 
factors were not among the most influential descriptors [34-36], indicating a 
minor role of weak and non-specific interactions between substrate and 
enzymes. In our previous QSARs on Km and Vmax for different metabolising 
enzymes, size and shape factors were relevant only for Km and less for the 
catalytic reaction Vmax [141]. The small role played by geometric factors in 
determining CLINT compared to electronic properties suggests that clearance 
rates are representing the catalytic rates, as already observed above from the 
absence of partitioning properties. Metabolic reactions are characterised by 
bond cleavage and formation, which are better explained by electronic factors. 
6.4.3 Practical application 
The QSARs obtained in the present study can be helpful to predict the in vitro 
CLINT values for human hepatocytes and liver microsomes. Information on 
hepatic clearance is essential for the extrapolation from in vitro to in vivo 
metabolism (ivive), useful for risk assessment. In order to express the 
clearances obtained from hepatocytes (µL/min/106 cells) and microsomes 
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(µL/min/mgMICR) in a common unit, the in vitro CLINT values needs to be 
multiplied by the in vitro system scaling factor (SF) to obtain the intrinsic 
clearance in the liver (CLINT,liver, L/min/gLIV). The in vitro SFs are hepatocellularity 
for hepatocytes (HP, 106 cells/gLIV) and protein concentration for microsomes 
(PL, mgPROT/gLIV). For humans, SF values of 99 10
6 cells/gLIV for HP and 32 
mgPROT/gLIV for PL have been estimated with a meta-analysis [154]. Then, liver 
CLINT values should be multiplied by liver weight (LW, gLIV/kg), which for 
humans is on average 25.7 gLIV/kg [155], to obtain the in vivo intrinsic clearance 
(CLINT,vivo, L/min/kg). In order to be incorporated into mass balance 
bioaccumulation models, established physiologically based models can be 
further used to extrapolate the in vitro intrinsic clearance to whole body in vivo 
biotransformation rates (km, min
-1) [19]. 
While beyond the scope of the present study, a comparison of the magnitude 
of the clearance rates measured in hepatocytes and microsomes assays and 
the application of ivive methods needs to be addressed in future studies. For 
microsomes, with 50% explained variance and 30% external predictivity, the 
QSAR can potentially be improved when more in vitro data become available 
from standardised experiments (possibly following substrate depletion). 
Despite these future efforts, the current study shows that the explained 
variance of 67% and external predictivity of 62% for hepatocytes is 




Appendix F contains the datasets collected for this study for human 
hepatocytes and microsomes, as well the applicability domains of the QSARs. 
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In environmental modelling, the prediction of the biotransformation rate is a 
difficult task due to the specific action of metabolism, which depends on the 
chemical and the enzyme involved and varies among individual organisms and 
species. The overall aim of this thesis was to develop QSARs for the prediction 
of biotransformation of xenobiotics in mammals based on their chemical 
properties. The relationships between metabolic activity and chemical 
structure were developed using different types of descriptors and for in vitro 
systems representing different levels of biological organization (isolated 
enzymes, hepatocytes and microsomes). The advantages and disadvantages of 
the QSAR descriptors and of the in vitro systems are presented in Section 7.2. 
The in vivo biotransformation rate km of chemicals can be obtained using 
different methods, as discussed in Section 1.2.2. For example, km can be 
estimated as the difference between measured elimination rate constants and 
the sum of elimination rate constants predicted assuming no metabolism [20, 
21]. Alternatively, km values can be estimated by extrapolating the metabolic 
constants measured in vitro to their whole-body in vivo equivalents using 
established physiologically based models [19]. In Section 7.3, an in vitro-in vivo 
extrapolation (ivive) scheme is first explained for tests with isolated 
hepatocytes and liver microsomes or isolated enzymes, which are the in vitro 
assays analysed in this thesis (Section 7.3.1). Second, this scheme is used to 
derive km values using the experimental clearance values collected for human 
microsomes and hepatocytes and the extrapolated km values were compared 
to in vivo measurements (Section 7.3.2). Finally, in Section 7.4 a method is 
discussed to quantify bioaccumulation potential of the metabolites without 
knowing their exact identity (i.e. molecular structure), based on the 
quantification of the change of hydrophobicity of the parent compound due to 
biotransformation (Chapter 2). 
 
7.2 Tentative comparison of the QSARs 
In this thesis, the relationships between metabolic activity and chemical 
structure were investigated using different types of descriptors: first Kow only, 
then mechanistic descriptors and finally theoretical descriptors. These models 
were developed for systems representing different levels of biological 
organization (isolated enzymes, microsomes and hepatocytes). The advantages 
and disadvantages of the models developed in Chapters 3 to 6 are listed in 
Table 7.1, with regard to the different descriptors and the different in vitro 
assays considered.  
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Table 7.1. Advantages and disadvantages of the three different approaches 
used to derive metabolic constants. 
QSAR Pros Cons 









+ Mechanistic interpretation - Relatively low explained variance 
+ Insights into the affinity to single 
enzymes 
- Not all metabolic pathways taken 
into account 
+ Km and Vmax can be easily derived 
for new chemicals, as values of 
predictors are widely available 
- Models were not validated, so 
predictions for new chemicals 
(which need to be putative 
substrates for the enzyme) could 
be unreliable 








+ Better statistical results 
compared to mechanistic 
descriptors 
- Some descriptors difficult to 
interpret 
+ Insights into the affinity for 
enzymes and catalytic reactions 
- Not all metabolic pathways taken 
into account 
+ Models were validated, so they 
can be used for predictive 
purposes 
- Most descriptors are difficult to 
calculate (commercial software) 
and chemicals need to be 











+ Satisfying statistics for 
hepatocytes, so QSAR could be 
used for ivive 
- Some descriptors difficult to 
interpret 
+ CLH values for the overall hepatic 
metabolism (for microsomes 
only P450), no need to know the 
metabolic pathway 
- Difficulty to differentiate all the 
factors influencing clearance 
(e.g. transport processes for 
hepatocytes, enzymatic 
reactions..) 
+ Models were validated, so they 
can be used for predictive 
purposes 
- Many descriptors are not widely 
available (e.g. commercial 
software) 
+ Inclusion of diverse 
environmental pollutants 
(previous studies in mammals 
were focused on 
pharmaceuticals only) 
- Data available for relatively few 
compounds (about 100 for 
dataset): more experimental in 




7.2.1 Advantages and disadvantages of the different descriptors 
Models in this thesis were built using a “mechanistic” approach for Km and Vmax 
of different enzymes in mammals (Chapters 3 and 4), as well as using a 
“theoretical” approach for enzymatic Km and Vmax (Chapter 5) and for CLINT 
from human hepatocytes and microsomes (Chapter 6). The main advantage of 
the first approach is that it enhances the understanding of the processes 
governing biotransformation, while the theoretical approach allows optimising 
the model performance for prediction (Table 7.1). Mechanistic descriptors are 
also widely available, while theoretical descriptors are often calculated with 
commercial software, thus they are not easily retrievable if they need to be 
calculate for new compounds. 
The metabolic action consists of two steps: binding and catalytic reactions, 
represented by 1/Km and Vmax, respectively. In addition, hepatocytes are liver 
cells; therefore, for these assays, also uptake (via passive diffusion or 
transporters) influences the clearance. Binding and partitioning processes take 
place through reversible or permanent bonding between the substance and 
enzyme active site or the cell membrane/transporters, in case of hepatocytes. 
Binding and passive diffusion usually involve weak interactions (e.g. van der 
Waals interactions or hydrogen bonding), except for substance binding to FMO 
(nucleophilic attack). On the contrary, catalytic reactions and active transport 
are governed by strong interactions (e.g. ionic bond or covalent bonding). 
Weak interactions are usually influenced by partitioning and size properties of 
the molecules, while strong interactions are governed by electronic factors [25, 
65]. 
Based on the a priori knowledge of the mechanism of biotransformation, the 
metabolic constants were expected to be mainly influenced by the following 
properties: 
- enzymatic Km: partitioning properties and size, as well as electronic factors 
influencing binding; 
- enzymatic Vmax: electronic properties governing chemical reactivity; 
- hepatocytes and microsomes clearance CLINT: electronic properties, as well 
as partitioning and size, influencing clearance (CLINT = Vmax/Km) and uptake 
(for hepatocytes). 
The regressions between 1/Km and hydrophobicity (Chapter 3) showed that 
binding increased with compound Log Kow, which can be understood from the 
tendency to transform lipophilic compounds into more polar, thus more easily 
excretable metabolites. Mechanistic insight was provided by the analysis of the 
slopes. For most of the substrate classes of ADH, ALDH and CYP, the resulting 
slopes had 95% Confidence Intervals covering the value of 0.6, typically noted 
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in the regressions between protein-water distribution (Log Kpw) and Log Kow. A 
reduced slope (0.2-0.3) was found for FMO: this may be due to a different 
reaction mechanism involving a nucleophilic attack. When the relationships 
between 1/Km and more mechanistic descriptors (such as area, hydrogen 
bonding, etc.) were investigated (Chapter 4), partitioning and size properties 
were the most important properties influencing binding for ADH and ALDH. For 
CYP and FMO, electronic properties, together with size for CYP, played a 
greater role in influencing 1/Km, and this was explained in relation to the 
catalytic mechanism of the enzymes. For FMO, this might be because of the 
metabolic mechanism involving a nucleophilic attack. CYP enzymes have a 
catalytic mechanism with many steps occurring between substrate binding and 
oxygenation [49]. It was shown that Km values may be sensitive to kinetic 
perturbations at catalytic steps taking place after substrate binding; thus, 1/Km 
values may not be good approximations of affinity constants [107]. In the 
relationships between Vmax and mechanistic descriptors (Chapter 4), electronic 
properties such as dipole moment and LUMO energy were the most relevant. 
This can be explained by the nature of the catalysis, which is characterised by 
the cleavage and formation of covalent or ionic bonds, thus strong 
interactions. 
While mechanistic descriptors were helpful to gain some insight into the 
processes governing biotransformation, the models had generally low 
explained variances (0.4 <Radj
2< 0.7 for Log (1/Km) and 0.2 <Radj
2< 0.5 for Log 
Vmax). This might indicate that the metabolic processes could only partly be 
explained by the physicochemical descriptors chosen, possibly because of the 
complexity of the underlying metabolic reactions [102]. The “theoretical” 
approach used to predict enzymatic Km and Vmax (Chapter 5) had better 
statistical performances (0.5 <Radj
2< 0.8 for Log (1/Km) and 0.2 <Radj
2< 0.8 for 
Log Vmax), but the interpretation of the descriptors selected was not 
straightforward, although some general interpretation of the QSARs was 
provided. The most relevant predictors for Km were functional groups or 
fragments for the enzymes metabolising specific compounds (ADH, ALDH and 
FMO) and size and shape properties for CYP, likely because of the broad 
substrate specificity of CYP enzymes. The Vmax values of FMO were 
independent of substrate chemical structure because the rate-limiting step of 
its catalytic cycle occurs before compound oxidation. For the other enzymes, 
Vmax was predominantly determined by functional groups or fragments and 
electronic properties because of the strong and chemical-specific interactions 
involved in the metabolic reactions. Besides the better statistics, an advantage 
of the models developed for enzymatic Km and Vmax is that external validation 
was performed, thus allowing extrapolation to other chemicals. In this case, it 
is however necessary to know whether the chemical is a putative substrate for 
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the enzyme, as well as whether it is within the applicability domain of the 
model. 
The “theoretical” approach employed to build the QSAR for CLINT of human 
hepatocytes and microsomes (Chapter 6) yielded satisfactory explained 
variances of 50% and 67%, respectively, but again the results were difficult to 
interpret. For both liver assays, clearance was predominantly determined by 
electronic properties, while size and shape were less important. As clearance is 
dependent on enzyme binding and membrane permeation (for hepatocytes), 
partitioning properties were expected to be influent in these QSARs, but they 
were not among the selected descriptors. The minor role of geometry and 
partitioning suggests that enzyme binding and, for hepatocytes, uptake across 
the membrane are not rate-limiting in vitro, thus clearance rates are 
representing the metabolic rate. Functional groups of fragments were useful to 
identify specific compounds that have a reaction rate significantly higher or 
lower compared to the other compounds, such as PCBs, which were poorly 
metabolised by hepatocytes and microsomes. The models were externally 
validated, thus they can be used to predict the in vitro hepatic clearance of 
other chemicals within the applicability domain. 
In conclusion, “theoretical” approaches should be used to obtain models that 
are able to predict the metabolic constants of heterogeneous groups of 
chemicals, such as the ones analysed in this thesis. Nevertheless, a preliminary 
exploration using basic physicochemical parameters (such as Log Kow, 
molecular size, etc.) as well as electronic features was helpful to explain the 
processes underlying biotransformation. 
7.2.2 Advantages and disadvantages of the in vitro assays 
In this thesis, QSARs were developed for systems representing different levels 
of biological organization (isolated enzymes, hepatocytes and microsomes). 
The Km and Vmax constants measured in enzymatic assays are a measurement 
of the metabolic potential relative to a specific pathway. The clearance values 
measured in microsomes and hepatocytes, instead, are related to the overall 
hepatic metabolism for hepatocytes and the first phase metabolism (mainly 
P450) for microsomes. As a consequence, when the QSAR for hepatocytes is 
used to predict the clearance of a new compound, it is not required to know its 
metabolic pathway. For microsomes, it should only be known whether Phase 1 
is the dominant metabolic process. This is an advantage over the models for 
the enzymes, for which the chemical should be a putative substrate for the 
enzyme and this is often difficult to know (Table 7.1). In addition, in vitro 
clearance values for hepatocytes and microsomes can be extrapolated to in 
vivo clearance values that are comparable to the measured values. On the 
contrary, ivive extrapolations performed using enzymatic constants might not 
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be reliable, as the in vitro assays contain higher concentration of isolated 
enzymes that do not reflect the in vivo situation. In Appendix G (Figure G1), a 
comparison between enzyme data and hepatocyte data collected for this 
thesis showed that the former are poor predictors of intrinsic liver clearances. 
The models developed for enzymes are however useful to have a better 
understanding of the processes taking place at the enzymatic level. It is also 
important to notice that the Km and Vmax data used to develop the QSARs for 
the different enzymes were averaged over different mammal species, while 
CLINT were measured only in human hepatocytes and microsomes. The merging 
of data from different species is another source of variability, thus care should 
be taken when using these models to obtain enzymatic Km and Vmax values for a 
species for which no experimental data were available. 
 
7.3 In vitro to in vivo extrapolation 
Data from in vitro metabolic tests are used to determine biotransformation 
potential of drugs and environmental pollutants in mammals and fish [19, 
138]. Since liver is the principal organ responsible for the metabolism [1], most 
in vitro systems are derived from hepatic tissue. The biotransformation 
potential is frequently assayed via the in vitro measurement of hepatic intrinsic 
clearance (CLINT) in isolated enzymes, microsomes, S9 fractions or hepatocytes 
[156]. Liver microsomes are subcellular fractions (endoplasmatic reticulum) 
with relatively high concentrations of Phase 1 drug-metabolising enzymes, 
especially cytochrome P450 (CYP). Liver S9 are subcellular fractions 
(microsomes and cytosol) containing cytosolic Phase 2 enzymes, such as 
glutathione S-transferase (GST). Isolated hepatocytes are liver cells, thus they 
contain the full complement of Phase 1 and Phase 2 metabolic enzymes. The 
rate of biotransformation of chemicals can be monitored either by the 
decrease in the amount of the substrate (parent compound) or by an increase 
in the products (metabolites) [22]. To be incorporated into mass balance 
bioaccumulation models, in vitro CLINT values must be extrapolated to estimate 
in vivo km for the whole-body [19].In this section, first a general scheme is 
presented to perform in vitro-in vivo extrapolations (ivive) (Section 7.3.1). This 
scheme is then used to derive km values using the experimental clearance 
values collected for human microsomes and hepatocytes. The extrapolated km 
values were compared to in vivo measurements in order to validate the ivive 
method in Section 7.3.2. 
7.3.1 In vitro to in vivo extrapolation scheme 
The intrinsic hepatic clearance in vitro (CLINT,vitro) is calculated as the ratio 
between the Vmax and Km experimental values (valid when [S] < 10%Km) [19]. 
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The units of CLINT,vitro depend on the in vitro system used: CLINT,vitro is expressed 
as L min-1 10-6 cells-1 for hepatocytes and as L min-1 mgPROT
-1 for liver 
microsomes or isolated enzymes. The procedure to perform ivive can be 
divided in 4 steps: 
1) CLINT,vitro is multiplied by the in vitro system scaling factor (SF) to obtain the 
intrinsic clearance in the liver (CLINT,liver, L min
-1 gLIV
-1): 
𝐂𝐋𝐈𝐍𝐓,𝐥𝐢𝐯𝐞𝐫 = CLINT,vitro × SF    (Eq. 7.1) 
The in vitro system scaling factors are hepatocellularity for hepatocytes (HP, 
106 cells gLIV
-1) and protein concentration for microsomes or isolated 
enzymes (PL, mgPROT gLIV
-1). 
2) CLINT,liver is scaled to the intrinsic clearance for the whole-body (CLINT,vivo, L 
min-1 kgBW
-1) via multiplication by liver weight (LW, gLIV kgBW
-1): 
𝐂𝐋𝐈𝐍𝐓,𝐯𝐢𝐯𝐨 = CLINT,liver × LW    (Eq. 7.2) 
3) A physiological model of the liver is applied to obtain the total hepatic 
clearance (CLH, L min
-1 kgBW
-1). The most widely used model type is the ‘well-
stirred tank’ model [19], which combines CLINT,vivo with the hepatic blood 
flow (QH, L min
-1 kgBW
-1) and a binding term (fU, /) to obtain CLH: 
𝐂𝐋𝐇 =  
QH∙fu∙CLINT,vivo
QH+fu∙CLINT,vivo
     (Eq. 7.3) 
The parameter fU is given by the ratio between unbound chemical fraction 
in blood plasma (fu,blood) and in the in vitro test system (fu,inc), assuming that 
only freely dissolved chemicals can be biotransformed. Studies showed that 
best predictions of in vivo clearances were obtained when disregarding fu 
(i.e. fu = 1) for the extrapolation of in vitro hepatic clearances measured for 
diverse drugs in rat microsomes [157] and in human microsomes and 
hepatocytes [146, 158]. For this reason, Eq. 7.3 is rewritten as follows: 
𝐂𝐋𝐇 =  
QH∙CLINT,vivo
QH+CLINT,vivo
     (Eq. 7.3a) 
4) Finally, CLH is divided by the volume of distribution of the compound (Vd, L 
kgBW
-1) and multiplied by a time conversion factor (1440 min d-1) to calculate 





× 1440      (Eq. 7.4) 
Table 7.2 lists the values of the biochemical and physiological parameters 
needed for the ivive (SF, LW, QH). The SF values for the in vitro tests in humans 
were derived from meta-analysis [154]. When no meta-analysis data were 
available, SF parameters were calculated as arithmetic average of the values 
reported in the papers where Km and Vmax values were collected (Appendix G, 
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Table G1). The values of LW and QH are reference values taken from a study 
that gathered and averaged data from the scientific literature for various 
physiological parameters in mammals [155]. The Vd (L kgBW
-1) values can be 
estimated with the empirical equations in Table 7.3 [159], which depend on 
Log Kow and charge state and were developed for drugs with human data. 
Table 7.2. Biochemical and physiological parameters for ivive of liver clearance 
in humans, including the scaling factors for hepatocytes (HP), microsomes 
(PCmicr) and the enzymes analysed in this thesis (PCCYP, PCADH, PCALDH and PCFMO). 





 99 [154], meta-analysis 
Protein content PCmicr mgPROT gLIV
-1
 32 [154], meta-analysis 
 PCCYP mgPROT gLIV
-1
 32 [154], meta-analysis 
 PCADH mgPROT gLIV
-1
 0.21 
This thesis, average 
(Appendix G) 
 PCALDH mgPROT gLIV
-1
 0.06 
This thesis, average 
(Appendix G) 
 PCFMO mgPROT gLIV
-1
 0.13 
This thesis, average pig 
and mouse (Appendix G) 
Liver weight LW gLIV kgBW
-1
 25.7 









[155], average literature 
values 
Table 7.3. Log Kow
a dependent prediction of Vd (L kgBW
-1) at various 
predominant charge states  at pH 7.4, taken from [159]. 
Predominant charge 












Uncharged (N) -3< Log Kow <5 1 2.8 
Uncharged (N) 5≤ Log Kow <7 10 4.3 
Negatively charged (A) -2< Log Kow <7 0.2 2.5 
Positively charged (B) -7< Log Kow ≤-2 0.3 1.1 





Positively charged (B) 5≤ Log Kow <8 20 6.1 
a
LogKow predicted with QSAR+ module of Cerius2 (v 4.6, Accelrys Inc, San Diego, USA). 
b
N = neutral, B = basic, A = acidic compounds. 
c
From Table 10 and Figure 3 in [159]. 
d
Fold Error = (exp. Vd/pred. Vd) or (pred. Vd/exp. Vd) whichever the greater. 
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7.3.2 Ivive for the data in this thesis for humans 
Here, the ivive method described in 7.3.1 is applied to a selection of 
compounds for which experimental CLINT data were available for both 
microsomes and hepatocytes. The aim is to compare the CLH values estimated 
with ivive to CLH values measured in vivo for hepatic metabolism. For this 
reason, data collected for specific enzymes are not included in the ivive as they 
reflect only one pathway per substance, while the interest here is to obtain CLH 
relative to the overall metabolism. 
Measured in vivo CLH values were retrieved from Paixão et al. 2010 [36], who 
calculated the clearance of 112 drugs from measured human intravenous in 
vivo pharmacokinetic data from Goodman et al. 2006 [160]. They collected 
data on intravenous total plasma clearance (CLtotal), fraction of drug eliminated 
by the kidneys, as well as oral bioavailability, and finally obtained hepatic in 
vivo CLH values from CLtotal by subtracting renal elimination routes and other 
non-hepatic ones.  
Among the pharmaceuticals for which measured in vivo CLH values were 
available, only the compounds included in both the hepatocytes (117 
compounds) and microsomes (115 compounds) datasets were selected, for a 
total of 22 pharmaceuticals. The estimated in vivo CLH of the 22 selected 
compounds were calculated by applying the ivive method in 7.3.1 to the 
experimental in vitro CLINT collected for hepatocytes and microsomes for 
Chapter 6 (Appendix E). 
The in vitro CLH values estimated with the ivive are reported in Table G2 of 
Appendix G for human hepatocytes and microsomes, together with the 
measured in vivo CLH values from Paixão et al. 2010 [36]. In Figure 7.1, the in 
vivo CLH values estimated for hepatocytes and microsomes were plotted 
against the measured in vivo CLH values. 
 
Figure 7.1 (next page). Log transformed values of in vivo CLH (L min
-1 kgBW
-1) for 
humans measured from in vivo experiments plotted against the CLH data 
calculated with the ivive described in Section 7.3.1 for hepatocytes (HC, white 
dots) and microsomes (MS, black dots). The black line represents the 1:1 line 
and the dotted lines the 10-fold and the 2-fold higher and lower intervals. 
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The Root Mean Squared Error (RMSE) and the percentage of predictions within 
10-fold and 2-fold difference were used to evaluate the performance of the 
ivive method to predict in vivo CLH for hepatocytes and microsomes. The RMSE 
is calculated as the square root of the ratio between the sum of the square of 
all errors and the number of observations, and in this case it is expressed in 
Log units. The RMSE values of 0.51 for hepatocytes and 0.55 for microsomes 
indicate a low accuracy in predicting the in vivo clearances using ivive. When 
looking at the percentages of estimated values below 2-fold error (64% for 
hepatocytes and 50% for microsomes), the results of this synthesis were in 
accordance with previously described values for ivive with human hepatocytes 
with less than 50% of compounds within 2-fold error [36, 161, 162]. The 
reasons for lack of prediction may be either the low ability of CLINT data 
measured in in vitro assays to represent the in vivo situation or inappropriate 
ivive method. More investigations are needed to improve the accuracy of ivive 
methods. 
In order to test whether the ivive has added value compared to the average of 
the in vivo measurements, the Coefficient of Efficiency (CoE) was calculated. 
The CoE is defined as one minus the ratio between the sum of the square of all 


































      (Eq. 7.6) 
Where O is the observed value (i.e. the measured in vivo CLH value from Paixão 
et al. 2010 [36]) and P the predicted value (i.e. the in vivo CLH value estimated 
with ivive) for the 22 compounds. The negative CoE values obtained for 
hepatocytes (-0.1) and microsomes (-0.3) indicate that the average of the in 
vivo measurements over the chemicals is a better predictor compared to the 
ivive estimates for this set of chemicals. Two chemicals are mainly responsible 
for the negative CoE: gemfibrozil and atenolol. For these two compounds, in 
vivo CLH values estimated from hepatocytes and microsomes are more than 
one order of magnitude higher than the measured value. In addition, for this 
set of compounds the measured clearance rates are almost all within one or of 
magnitude, with the exception of atenolol. It is therefore recommended to 
repeat this analysis on a larger dataset with a wider range of clearance rates, 
when data will be available. 
For the compounds analysed in this synthesis, clearances estimated using data 
from hepatocytes provide better results compared to microsomes data. This is 
probably because of the higher quality of the hepatocytes data, most of which 
were taken from controlled experiments. Moreover, isolated hepatocytes are 
liver cells, thus they contain the full complement of Phase 1 and Phase 2 
metabolic enzymes and essential cofactors (e.g. NADPH). This means that all 
possible metabolic reactions can take place in hepatocytes and most 
transporter functions are preserved, better mimicking the in vivo systems 
[143]. Therefore, predictions of in vivo CLINT from hepatocytes data are usually 
more accurate than those from microsomal data [144], as microsomes assays 
provide exhaustive CLH values only when CYP metabolism is the dominant 
biotransformation pathway [143]. Most of CLH values were overestimated 
using ivive, i.e. 14 compounds for hepatocytes and 17 for microsomes. This is 
in contrast with previous studies, in which CLH in hepatocytes were generally 
underpredicted with ivive, for different reasons (e.g. neglect of extrahepatic 
metabolism, quality of cryopreserved hepatocytes, under-prediction potential 
of well-stirred model, etc.). The possible reasons for overestimation may be in 
the ivive method. The overestimation of CLH, and therefore the prediction of 
higher km values, may lead to an underestimation of internal concentrations of 
chemicals. More studies are needed to determine the improvement of 
bioaccumulation models in mammals when biotransformation rates are 
included. 
In conclusion, for the limited number of compounds analysed in this synthesis, 
the extrapolation of in vitro CLH from human hepatocytes provided in vivo CLH 
that were closer to the observed in vivo CLH compared to the microsomes 
results. This is in concordance with previous studies in which hepatocytes 
 Chapter 7 | 113 
generally provided more reliable estimation of the in vivo clearance due to 
their greater ability to mimic the in vivo situation. In order to have more 
extensive conclusions, additional data from in vitro experimental 
measurements are necessary for diverse compounds, for which in vivo CLH 
values are already available in e.g. Paixão et al. 2010 [36]. 
 
7.4 Change of hydrophobicity after metabolism 
In Chapter 2, the change of Kow after metabolism was quantified for parent 
compounds undergoing individual oxidation reactions catalysed by CYP, ADH 
and ALDH. For reactions metabolised by CYP, the Kow of the metabolite was on 
average a factor of 10 lower if compared to the Kow of its parent compound. 
For oxidations mediated by ALDH and ADH, the Log Kow generally remained 
unchanged after metabolism. In a more recent and extensive study, Kirchmair 
et al. quantified the shift of Log Kow for thousands of experimentally observed 
metabolic reactions of drugs as well as endobiotic compounds [164]. For drugs, 
the Kow of the metabolites was on average a factor of 10 lower than the Kow of 
the corresponding parent compound. This means that on average Log Kow,M = 
Log Kow,P -1. This method provides information on the elimination rates of the 
metabolites in comparison to the parent compound. Metabolites are generally 
less hydrophobic (on average 10 times less), thus they are excreted faster as 
they would tend to accumulate to a lesser extent in fat. 
A drawback of this estimation is that in reality it is very difficult to anticipate 
through which pathway(s) a compound is metabolised, sometimes even 
leading to metabolites with an increased Kow. The main advantage of this 
method is that it allows to quantify the Kow of metabolites based on the Kow of 
the parent compound without knowing the identity (i.e. molecular structure) 
of the metabolites. This could be useful for risk assessment, as it is difficult to 
determine the molecular structure of metabolites for all parent compounds of 
interest. For example, the elimination constant of the metabolite (kex, d
-1) can 
be estimated from species weight and compound Kow (equation by Hendriks et 
al. [15]) by using a Kow of one order of magnitude lower than the Kow of the 
parent compound. In combination with an estimated biotransformation rate 
for the parent compound (e.g. using ivive from a measured in vitro CLINT or 
from a CLINT predicted with the hepatocytes QSAR in Chapter 6), this would 
allow to estimate the accumulation of the parent compound and its 




Substances that are taken up by organisms can be transformed through 
metabolic reactions, which contribute to their elimination. This process needs 
to be considered in the overall risk assessment, but the inclusion of 
metabolism in bioaccumulation models is still difficult. Biotransformation rates 
are difficult to obtain due to the complex processes involved, which depend on 
the distribution of the chemical and on the enzymatic action (binding to the 
enzyme and catalytic reaction). In addition, metabolic pathways are frequently 
not fully known and may differ depending on organisms and species. In order 
to understand better the processes influencing biotransformation, QSARs 
models were developed for metabolic constants in mammals, namely Km and 
Vmax of 4 oxidising enzymes (Chapters 3-5) and CLINT of human hepatocytes and 
microsomes (Chapter 6).  
The advantages and disadvantages of the models developed in Chapters 3 to 6 
are also discussed in Chapter 7, with regard to the different descriptors and 
the different in vitro assays considered. While the QSARs for individual 
enzymes were helpful to interpret metabolic processes, their application to 
risk assessment is yet limited. Instead, the most promising results were 
obtained with human hepatocytes and microsomes. Especially for hepatocytes, 
the QSAR statistics are encouraging, allowing application of the outcomes in 
ivive. The performances of the QSARs are limited by the reliability of the in 
vitro assay systems [165]. The models can potentially be improved when more 
in vitro data become available from standardised experiments.  
In addition, a general scheme for in vitro to in vivo extrapolation (ivive) was 
presented in Chapter 7 to estimate the biotransformation constant of 
chemicals needed for risk assessment. The ivive method was applied to derive 
km values using in vitro clearance values collected for human microsomes and 
hepatocytes in Chapter 6. The extrapolated km values were compared to in vivo 
measurement. The performances of the models were, however, limited by the 
reliability of the in vitro assay systems. The scheme needs to be validated on a 
wide array of chemicals, yet it could be useful for a first estimate of km in a 




















P450 = cytochrome P450 enzymes; ADH = alcohol dehydrogenase; ALDH = 
aldehyde dehydrogenase; PCBs = Polychlorinated biphenyls; PCDDs = 
Polychlorinated dibenzodioxins; PCDFs = Polychlorinated dibenzofurans; PBDEs 
= Polybrominated diphenyl ethers; PBBs = Polybromo biphenyls; PAHs = 
Polycyclic aromatic hydrocarbons; NHAs = Nitrogen heterocyclic aromatic 
compounds; OP = Organophosphorus; AA = Aromatic amines. 
 
Table A1. Biotransformation reactions included in this study, with the typical 




Chemical class of parent 
compounds 
Reactions on chemical moieties 




PCBs, aromatic hydrocarbons, 
heterocyclic compounds, 




(alkanes and ketones), 
aromatic hydrocarbons, cyclic 






















AA (primary, secondary), 
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(primary alcohols, allylic 
alcohols, glycols, glycol 








(secondary alcohols, allylic 
alcohols, cyclic compounds). 
 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Formulas of the statistical coefficients used as measures of model fitting and 
predictive power. 
 
Coefficient of determination (R2) 
R2 = 1 – (RSS/SSy) 
The Residual Sum of Squares (RSS) is the sum of the squared difference 
between the experimental response (y) and the response calculated by the 
model (ŷ):  
 RSS = ∑ (yi − ŷi)
2n
i=1  
The total Sum of Squares (SSY) is the sum of the squared differences between 
the experimental response (y) and the average experimental response (?̅?): 




Adjusted coefficient of determination (R2adj) 
R2adj = 1-(1-R
2)(n-1)/(n-p) 
where n is the number of compounds in the dataset and p is the number of 
variables. 
 
Root Mean Squared Error (RMSE) 
RMSE = √ (RSS/n) 
where n is the number of compounds in the dataset. 
 
Leave-one-out cross-validated R2 (Q2LOO) 
QLOO
2 = 1 - (PRESS/SSy) 
The Predictive Error Sum of Squares (PRESS) is the sum of the squared 
differences between the experimental response (y) and the response predicted 
by the model for the object that was not used for model estimation (yi/i): 
 PRESS = ∑ (yi − ŷi/i)
2n
i=1  
where the notation i/i indicates that the response is predicted by a model 
estimated when the i-th compound was left out from the training set. 
 




RMSE of the Leave-one-out cross-validation (RMSELOO) 
RMSELOO = √ (PRESS/n) 
where n is the number of compounds in the dataset. 
 
Akaike’s information criterion (AIC) 
AIC = RSSx(n + p′) (n − p′)2⁄  






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table B2. Data conversion for rates. 
Catalytic rates were reported in the papers with heterogeneous units and with 
different constants (i.e., as Vmax or as kcat). Therefore, it was necessary to 
standardise the data. We expressed all rates as Vmax, using μmol min
-1 mgPROT
-1 
as units. For CYP enzymes, Vmax was referred to the microsomal protein weight, 
whereas for the other enzymes Vmax was referred to the enzyme weight, i.e., 
mgPROT=mgMICR PROT and mgPROT=mgENZ, respectively. The rates expressed as kcat 
(min-1) were transformed into Vmax values. 
For ADH, ALDH and FMO, Vmax (expressed as μmol min
-1 mgENZ
-1) was derived 











For CYP, we transformed the kcat in Vmax values (expressed as μmol min
-1 
mgPROT
-1) using the specific content of the enzyme (E, nmol mgMICR PROT
-1) [29]:  
Vmax = 𝑘cat ∙ [E] ∙ 10
−3    (eq.2) 
[μmol min−1mgMICR PROT
−1 ]
= [min−1] ∙ [nmol  mgMICR PROT
−1 ] ∙ [μmol nmol−1] 
In case Mr or [E] values were not reported in the paper where we collected kcat, 
we used average values coming from other studies. 





























































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





























































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   























































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   






























































































































































































































































































































































































































































































































































    
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

















































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   



























































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table C6. List of the 22 substituted benzaldehydes present in ALDH database; 
their general structure is also reported with the positions of the substituents. 
General structure of 
substituted benzaldehydes 




Aldehydes (Mono) + 
Dinitrobenz. 
2,4-dinitrobenzaldehyde 
Aldehydes (Mono) 3,4-dimethoxybenzaldehyde 
Aldehydes (Mono) + Phenols m-hydroxybenzaldehyde 
Aldehydes (Mono) m-methoxybenzaldehyde 
Aldehydes (Mono) m-methylbenzaldehyde 
Aldehydes (Mono) o-bromobenzaldehyde 
Aldehydes (Mono) o-chlorobenzaldehyde 
Aldehydes (Mono) o-fluorobenzaldehyde 
Aldehydes (Mono) + Phenols o-hydroxybenzaldehyde 
Aldehydes (Mono) o-methoxybenzaldehyde 
Aldehydes (Mono) o-methylbenzaldehyde 
Aldehydes (Mono) o-nitrobenzaldehyde 
Aldehydes (Mono) p-(dimethylamino)-benzaldehyde 
Aldehydes (Mono) p-bromobenzaldehyde 
Aldehydes (Mono) p-carboxybenzaldehyde 
Aldehydes (Mono) p-chlorobenzaldehyde 
Aldehydes (Mono) p-cyanobenzaldehyde 
Aldehydes (Mono) p-fluorobenzaldehyde 
Aldehydes (Mono) p-iodobenzaldehyde 
Aldehydes (Mono) p-methoxybenzaldehyde 
Aldehydes (Mono) p-methylbenzaldehyde 
Aldehydes (Mono) p-nitrobenzaldehyde 
a







Table C7. Relationships between Log Kow and Log (1/Km) for ALDH in rat (with 
and without substituted benzaldehydes), including also their ranges and 95% 









































 The underlined values indicate non significant regression (p>0.05) 
 
Figure C1. Relationship between Log Kow and Log (1/Km) in rat for compounds 
metabolised by ALDH. Regressions (solid lines) and 95% confidence intervals 
(dashed lines). Laboratory measurements (dots): Log transformed geometrical 
mean of 1/Km [μM
-1] for each compound, with the geometric standard 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table E1. Applicability domains (AD) for Log (1/Km) QSARs, defined by the 
range (min and max) of the values of the descriptors for the data in the 
training sets. For each enzyme, also the range (min and max) of Log (1/Km) 
values are reported. 
Enzyme Name Group AD training set AD test set 
ADH nOHs Dragon6 (0; 2) (0; 1) 
 SIC4 Dragon6 (0; 0.97) (0; 0.84) 
 Mor23u Dragon6 (-2.59; 0.04) (-1.79; 0.14) 
 Log (1/Km)  (-5.75; -1.16) (-4.76; -1.44) 
ALDH 3DACorr_PiChg_2 Adriana (-0.07; 0.16) (-0.04; 0) 
 MATS5v Dragon6 (-0.30; 0.76) (-0.25; 0.74) 
 Mor01e Dragon6 (17.7; 751) (6.6; 440) 
 XLogP CDK (-0.53; 6.83) (-0.70; 4.57) 
 InertiaY Adriana (9.03; 1680) (1.76; 1760) 
 Log (1/Km)  (-2.51; 3.15) (-2.49; 3) 
FMO RHSA CDK (0.53; 1) (0.58; 1) 
 Se1N1N2ss E-state (0; 6.31) (0; 6.13) 
 N-067 Dragon6 (0; 2) (0; 2) 
 Hy Dragon6 (-0.93; 3.20) (-0.94; 5) 
 2DACorr_LpEN_1 Adriana (2.38; 285) (2.57; 146) 
 R4e+ Dragon6 (0; 0.18) (0; 0.17) 
 Log (1/Km)  (-4.60; -0.21) (-4.54; -0.26) 
CYP AROM Dragon6 (0; 1) (0; 1) 
 ATS7v Dragon6 (0; 3.15) (0; 3.19) 
 PDI Dragon6 (0.62; 0.997) (0.72; 0.95) 
 RTu Dragon6 (7.1; 30.3) (8.8; 24.6) 
 JGI5 Dragon6 (0; 0.08) (0; 0.08) 
 C2SP3 CDK (0; 9) (0; 8) 
 Log (1/Km)  (-4.71; -0.37) (-4.70; -1.28) 
  




Table E2. Applicability domains (AD) for Log Vmax QSARs, defined by the range 
(min and max) of the values of the descriptors for the data in the training sets. 
For each enzyme, also the range (min and max) of Log Vmax values are reported. 
Enzyme Name Group AD training set AD test set 
ADH nHDon Dragon6 (0; 3) (0; 1) 
 tautomercount Chemaxon (1; 2) (1; 2) 
 Mor15s Dragon6 (-2.62; 5.73) (-0.87; 0.80) 
 ASP Dragon6 (0.16; 0.97) (0.27; 0.90) 
 Log Vmax  (-0.32; 1.93) (-0.70; 1.45) 
ALDH nArX Dragon6 (0; 1) (0; 1) 
 R6m+ Dragon6 (0; 0.32) (0; 0.50) 
 Mor26e Dragon6 (-0.26; 0.42) (-0.23; 0.45) 
 WNSA-1 CDK (37.8; 231) (26.4; 163) 
 Log Vmax  (-2.50; 0.84) (-1.64; 0.63) 
FMO Se1C3N3as EState (0; 5.84) (0; 6.3) 
 Se2C3O1s E-state (0; 11.9) (0; 9.78) 
 Log Vmax  (-1.31; 0.40) (-1.10; 0.36) 
CYP Se1C1C3sd E-state (0; 2.01) (0; 2.07) 
 Mor24s Dragon6 (-1.56; 3.40) (-1.17; 1.12) 
 Mor10s Dragon6 (-4.64; 6.18) (-3.37; 2.42) 
 formalcharge_pH_7.4 Chemaxon (-1; 1) (-1; 1) 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table F3. Applicability domains (AD) for Log CLINT QSARs for human 
hepatocytes and microsomes, defined by the range (min and max) of the 
values of the descriptors for the data in the training sets. Also the range (min 
and max) of Log CLINT values are reported. 
Assay Name Group AD training set AD test set 
Hepatocytes 2DACorr_SigChg_5 Adriana (-0.42; 0.71) (-0.64; 0.43) 
 R8u+ Dragon6 (0.00; 0.05) (0.00; 0.05) 
 R5e+ Dragon6 (0.02; 0.13) (0.02; 0.10) 
 2DACorr_SigChg_2 Adriana (-0.96; 0.03) (-0.75; -0.02) 
 HATS0m Dragon6 (0.06; 3.35) (0.06; 3.44) 
 Log CLINT  (-5.57; 2.23) (-5.03; 1.88) 
Microsomes smallestringsize Chemaxon (0.00; 6.00) (0.00; 7.00) 
 GATS4v Dragon6 (0.00; 1.39) (0.72; 1.39) 
 Se2O1P4s E-States (0.00; 8.87) (0.00; 0.00) 
 2DACorr_SigChg_9 Adriana (-0.14; 0.41) (-0.24; 0.37) 
 HATS5e Dragon6 (0.00; 1.21) (0.17; 1.19) 
 Se2C2O1s E-States (0.00; 7.87) (0.00; 0.00) 
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Tentative comparison between hepatocytes and enzymes 
In this synthesis, an empirical equation has been derived to compare the 
clearance measured in hepatocytes to the clearance measured in enzymes: 
CLhepatocytes=f(Vmax,enzyme/Km,enzyme). 
For this purpose, the datasets were examined to find compounds with data 
available for hepatocytes and for enzymes. In total, the human hepatocytes 
dataset had 11 compounds in common with the enzymes datasets (4 chemicals 
for CYP and 7 for FMO, none of them measured in humans). In order to 
compare the metabolic constants of hepatocytes to the ones obtained in the 
enzymatic assays, the clearance values were expressed as intrinsic liver 
clearances (CLINT,liver, L min
-1 gLIV
-1) by multiplying the in vitro CLINT (i.e. the ratio 
Vmax/Km) by the in vitro system scaling factor (SF), as explained in Section 7.3.1 
The values of the SFs were taken from Table 7.2 and are 106 cells gLIV
-1 for 
human hepatocytes, 32 mgPROT gLIV
-1 for CYP and 0.13 mgPROT gLIV
-1 for FMO 
(average of pig and mouse values). As FMO and CYP data are values averaged 
over different species, the ivive was not performed and the liver CLINT values 
were directly compared for hepatocytes and enzymes data. 
For the 11 compounds metabolised by CYP and FMO, the relationship with the 
hepatocytes data was not statistically relevant, with R2 < 0.1. For all 
compounds, the clearances for hepatocytes were more than 10 fold lower than 
for enzymes (Figure G1). This can be due to the fact that the enzyme 
concentrations used for in vitro assays are higher than those that are present 
in the in vivo situation, so clearances may be higher than in vivo. Given the low 
statistics (r2 < 0.1), and as hepatocytes were quite able to represent the in vivo 
situation as shown in Section 7.3.2, enzymatic data seem less suitable to 
perform ivive. 
 
Figure G1 (next page). Ratio (Log 10 scale) between the in vivo liver hepatic 
clearances CLINT (L min
-1 gLIV
-1) measured in hepatocytes and in enzymes (CYP: 
green triangles; FMO: white dots) for 11 compounds for which data were 
available, in relationship with their Log Kow. The black line represents a ratio of 
1 (value in HC = value in MS) and the two dotted lines the 2-fold lower and 
higher error. 
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Table G1. For ADH, ALDH and FMO enzymes there is no tabulated value for the 
scaling factors. The content of enzyme in liver was taken from the papers 
measuring Km and Vmax, but this value was reported only in few studies. It also 
varies for the same species and/or isoenzyme. Here are the cases in which the 
scaling factor was available for ADH, ALDH and FMO: 
ADH (out of a total of 13 articles and 199 records) 
Ref # records Species Isoenzyme Protein weight (mgPROT gLIV
-1
) 
[282] 8 Human ADH1 0.07 
[270] 13 Human ADH2 0.405 
[285] 15, 7 Rat ADH1, ADH3 0.006, 0.017 
[286] 12 Human ADH1 0.322 
[287] 13 Horse ADH1 0.013 
[273] 5 Human ADH3 0.041 
Total: 73 All species Average (±st.d.): 0.12 (±0.17) 

































ALDH (out of a total of 17 articles and 244 records) 
Ref # records Species Isoenzyme Protein weight (mgPROT gLIV
-1
) 
[291] 1 Human ALDH3 0.003 
[292] 10, 9 Horse ALDH1, ALDH2 0.003, 0.002 
[294] 2, 2 Human ALDH1, ALDH2 0.033, 0.083 
[297] 6 Human ALDH3 0.011 
[300] 2,2 Human ALDH1, ALDH2 0.048, 0.170 
[303] 15, 14 Rat ALDH1, ALDH2 0.028, 0.011 
Total: 63  Average (±st.d.): 0.04 (±0.05) 
  Human Average (±st.d.): 0.06 (±0.06) 
 
FMO (out of a total of 22 articles and 263 records) 
Ref # records Species Isoenzyme Protein weight (mgPROT gLIV
-1
) 
[313] 15, 17 Mouse, Pig FMO 0.015, 0.254 
Total: 32  Average (±st.d.): 0.13 (±0.17) 
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Table G2. In vivo CLH (L min
-1 kgBW
-1) for human measured from in vivo 
intravenous pharmacokinetics experiments for 22 pharmaceuticals (data from 
Paixão et al. 2010 [36]), together with the in vivo CLH (L min
-1 kgBW
-1) estimated 
applying the ivive method described in Section 7.1.1 to in vitro CLINT data from 
human hepatocytes (HC) and microsomes (MS). The CLINT data used for the 
ivive are in Table X of Appendix X. The ratio between CLH measured in vivo and 
CLH extrapolated from HC and MS data are also reported (**if difference 


















sildenafil A 1.65 1.5 0.006 0.010 0.6 0.015 0.4* 
diclofenac A 4.26 1.1 0.007 0.015 0.5 0.019 0.4* 
gemfibrozil A 4.39 1.51 0.001 0.014 0.1** 0.013 0.1** 
atenolol B 0.43 -1.8 0.000 0.004 0.0** 0.007 0.0** 
naloxone B 1.62 0.85 0.018 0.016 1.1 0.007 2.4* 
metoprolol B 1.76 -0.47 0.014 0.003 4.4* 0.003 4.5* 
quinidine B 2.51 0.86 0.004 0.004 1.0 0.006 0.8 
propranolol B 2.58 0.36 0.015 0.005 2.7* 0.010 1.5 
risperidone B 2.63 1.25 0.008 0.011 0.7 0.013 0.6 
diltiazem B 2.73 1.89 0.011 0.009 1.2 0.012 0.9 
carvedilol B 3.42 2.07 0.012 0.016 0.7 0.018 0.7 
clozapine B 3.52 1.1 0.005 0.010 0.5 0.005 1.0 
diphenhydramine B 3.65 2.17 0.006 0.002 2.7* 0.003 1.7 
amitriptyline B 4.81 2.48 0.010 0.003 4.0* 0.008 1.3 
cimetidine N -0.11 -0.22 0.003 0.013 0.3* 0.006 0.5 
paracetamol N 0.91 0.9 0.002 0.002 1.2 0.005 0.5* 
methylprednisolone N 1.56 1.56 0.004 0.004 0.8 0.011 0.3* 
prazosin N 1.65 1.43 0.004 0.007 0.6 0.005 0.8 
nifedipine N 1.82 1.81 0.004 0.013 0.3* 0.017 0.3* 
zolpidem N 3.02 3.01 0.006 0.005 1.1 0.006 1.0 
diazepam N 3.08 3.08 0.001 0.001 0.6 0.003 0.2* 
midazolam N 3.33 3.28 0.008 0.013 0.6 0.019 0.4* 
a
 Compounds were classified as acid (A) if pKa1 ≤ 7.4, base (B) if pKb1 ≥ 7.4, otherwise neutral (N) 
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Summary 
Quantifying biotransformation of xenobiotics in mammals 
Biotransformation is one of the processes that influence the bioaccumulation 
of chemicals by decreasing the concentration of chemicals in an organism. In 
order to be metabolised, a chemical needs to bind to an enzyme and then a 
catalytic reaction takes place. Compounds are usually transformed into more 
hydrophilic metabolites, which are more easily eliminated from the organism. 
Predicting the biotransformation rate of a chemical is, however, a difficult task 
due to the specific action of metabolism, which depends on the chemical and 
the enzymes involved. 
The aim of this thesis was to develop models for the prediction of 
biotransformation of xenobiotics (pharmaceuticals and environmental 
pollutants) in mammals based on their chemical properties. The relationships 
between metabolic activity and chemical structure were performed for in vitro 
systems representing different levels of biological organization (i.e. isolated 
enzymes, hepatocytes and microsomes). The mechanisms underlying 
metabolism were investigated starting from the enzyme level. The focus was 
on the liver metabolism in mammals mediated by four important oxidising 
enzymes: alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH), 
flavin-containing monooxygenase (FMO) and cytochrome P450 (CYP) enzymes. 
Different types of descriptors were used in the model development, including 
the octanol-water partitioning coefficient (Kow), mechanistic descriptors and 
theoretical descriptors. 
In Chapter 2, the change in hydrophobicity, expressed as Kow, was quantified 
for organic pollutants undergoing various biotransformation reactions in 
mammals. The Kow values of a selected dataset of parent compounds were 
compared with the Kow of their first metabolites following oxidation reactions 
catalysed by CYP, ADH and ALDH. The Kow decreased up to two orders of 
magnitude, depending on the metabolic pathway. For reactions mediated by 
CYP, the decrease in Kow was one order of magnitude for hydroxylated and 
epoxidated compounds and two orders of magnitude for dihydroxylated and 
sulphoxidated xenobiotics. In contrast, no significant change in hydrophobicity 
was observed for compounds N-hydroxylated by CYP and for alcohols and 
aldehydes metabolised by ADH and ALDH. These relationships estimate the 
extent to which the elimination of pollutants is increased by 
biotransformation. Thus, the quantification of the Kow reduction might be 
considered as a first step in predicting biotransformation rates, but further 
studies are needed to investigate the feasibility of this approach. 
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In Chapter 3, binding affinity, expressed as 1/Km was related to compound 
hydrophobicity, expressed as Kow, for compounds oxidised by ADH, ALDH, FMO 
and CYP enzymes. For all regressions, 1/Km increased with compound Kow, 
which can be understood from the tendency to biotransform hydrophobic 
compounds into more polar, thus more easily excretable metabolites. 
Hydrophobicity was relevant to the binding of most of the substrate classes of 
ADH, ALDH and CYP. The resulting slopes had 95% Confidence Intervals 
covering the value of 0.6, typically noted in protein-water distribution 
regressions on the basis of Kow. If weak interactions are dominant, the 
partitioning of organic chemicals over various phases is governed by 
hydrophobicity and polarity, thus it can be related to compound Kow. A reduced 
slope (0.2−0.3) was found for FMO: this may be due to a different reaction 
mechanism involving a nucleophilic attack, which is a strong interaction thus it 
cannot be explained with compound Kow. 
In Chapter 4, models were developed to better understand how binding 
affinity (1/Km) and maximum reaction rate (Vmax) for substrates of ADH, ALDH, 
FMO and CYP in mammals relate to partitioning, geometric characteristics and 
electronic properties of the substrates. The explained variance of the models 
varied between 20% and 70% and was larger for 1/Km than for Vmax. The 
increase of 1/Km with compound hydrophobicity and size suggests that weak 
interactions are important, e.g. by substrate binding via desolvation processes. 
The importance of electronic factors for 1/Km was described in relation to the 
catalytic mechanism of the enzymes. Vmax was particularly influenced by 
electronic properties, such as dipole moment and energy of the lowest 
unoccupied molecular orbital. This can be explained by the nature of the 
catalysis, characterised by the cleavage and formation of covalent or ionic 
bonds (strong interactions). 
In Chapter 5, predictive models were developed for the enzymatic constants 
using theoretical descriptors. A genetic algorithm was employed to select at 
most six predictors from a pool of over 2000 potential molecular descriptors 
using two-thirds of the xenobiotics in each enzyme class. The resulting multiple 
linear models were cross-validated using the remaining one-third of the 
compounds. The explained variances (R2adj) of the models were between 50% 
and 80% and the predictive abilities (R2ext) between 50% and 60%, except for 




ext less than 30%. The Vmax values 
of FMO were independent of substrate chemical structure because the rate-
limiting step of its catalytic cycle occurs before compound oxidation. For the 
other enzymes, Vmax was predominantly determined by functional groups or 
fragments and electronic properties because of the strong and chemical-
specific interactions involved in the metabolic reactions. The most relevant 
predictors for 1/Km were functional groups or fragments for the enzymes 
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metabolising specific compounds (ADH, ALDH and FMO) and size and shape 
properties for CYP, likely because of the broad substrate specificity of CYP 
enzymes.  
Successively, 1/Km and Vmax values were also collected for whole liver cells and 
sub-cellular fractions (hepatocytes and microsomes) to build models predicting 
in vitro clearance (CLINT, i.e. Vmax/Km) for humans. In Chapter 6, multiple linear 
models were built and validated selecting at most 6 predictors from a pool of 
over 2000 potential molecular descriptors. For the hepatocytes model, the 
explained variance (R2adj) was 67% and the predictive ability (R
2
ext) was 62%. 
For the microsomes model, R2adj was 50% and R
2
ext 30%. For both liver assays, 
the most important descriptor relates to electronic properties of the 
compound. Functional groups of fragments were useful to identify specific 
compounds that have a deviating reaction rate compared to the others, such 
as Polychlorobiphenyls (PCBs) and organic amides which were poorly 
metabolised. 
Finally, in Chapter 7 the advantages and disadvantages of the different types of 
descriptors and levels of biological organization were discussed. While the 
models for individual enzymes were helpful to interpret metabolic processes, 
their application to risk assessment is limited. Instead, the most promising 
results were obtained with human hepatocytes. In addition, a general scheme 
to perform in vitro-in vivo extrapolations (ivive) was proposed and evaluated. 
The performances of the models were, however, limited by the reliability of 
the in vitro assay systems. The models can potentially be improved when more 
in vitro data become available from standardised experiments. In addition, the 
ivive method needs to be validated on a wide array of chemicals, yet it could 




Kwantificeren van biotransformatie van lichaamsvreemde stoffen in 
zoogdieren 
Biotransformatie is één van de processen die de bioaccumulatie van chemische 
stoffen beïnvloeden door de concentratie in organisme te verminderen. Om 
gemetaboliseerd te worden moet een stof binden aan een enzym waarna een 
katalytische reactie plaatsvindt. Stoffen worden meestal omgezet naar meer 
wateroplosbare metabolieten, die makkelijker geëlimineerd worden door het 
organisme. Het voorspellen van de biotransformatie snelheid is echter lastig 
vanwege de specifieke werking die afhangt van de stof en de betrokken 
enzymen. 
De doelstelling van dit proefschrift was het ontwikkelen van modellen om de 
biotransformatie van lichaamsvreemde stoffen (xenobiotica, t.w. medicijnen 
en milieu-verontreinigingen) in zoogdieren te voorspellen op basis van hun 
chemische eigenschappen. De relaties tussen de metabole activiteit en de 
chemische structuur werden gelegd voor in vitro systemen die verschillende 
niveau’s van biologische organisatie (d.w.z. geïsoleerde enzymen, levercellen 
en microsomen) representeren. De onderliggende mechanismen werden 
onderzocht, allereerst op het niveau van enzymen. The focus lag op afbraak in 
de lever door vier belangrijke oxiderende enzymen: alcohol dehydrogenase 
(ADH), aldehyde dehydrogenase (ALDH), flavin-containing monooxygenase 
(FMO) en cytochrome P450 (CYP). Verschillende typen descriptoren werden 
gebruikt in de modelontwikkeling, waaronder de octanol-water partitie 
coefficent (Kow), alsook mechanistische en theoretische descriptoren. 
In Hoofdstuk 2 is de verandering in de hydrofobiciteit, uitgedrukt in Kow, 
gekwantificieerd voor organische stoffen die verschillende biotransformatie 
reacties ondergaan in zoogdieren. The Kow waarden van een dataset van 
moederstoffen is vergeleken met de Kow van hun eerste metabolieten volgend 
op oxidatie reacties, gecatalyseerd door CYP, ADH en ALDH. De Kow nam tot 
twee ordes van grootte af, afhankelijk van de metabole route. Voor CYP 
gemedieerde reacties, was de afname in Kow één orde van grootte voor 
gehydroxyleerde en geëpoxideerde stoffen en twee ordes van grootte voor 
gedihydroxyleerde and gesulfoneerde xenobiotica. Daarentegen was de 
afname in hydrofobiciteit niet significant voor door CYP N-gehydroxyleerde 
stoffen en door ADH en ALDH gemetaboliseerde alcoholen en aldehydes. Met 
deze relaties kan de mate waarin eliminatie verhoogd is door biotransformatie 
geschat worden, maar vervolgstudies zijn nodig om de haalbaarheid van deze 
benadering te onderzoeken. 
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In Hoofdstuk 3 is de bindingsaffiniteit, uitgedruk als 1/Km gerelateerd aan de 
hydrophobicity, uitgedrukt als Kow, voor stoffen die worden geoxideerd door 
ADH, ALDH, FMO en CYP enzymen. In alle regressies nam 1/Km toe met de Kow 
van de stof, hetgeen kan worden verklaard door de neiging om hydrofobe 
verbindingen om te zetten in meer polaire, en dus makkelijker uit te scheiden 
metabolieten. Hydrophobicity was relevant voor de binding van de meeste 
substraat klassen voor ADH, ALDH en CYP. De resulterende hellingen hadden 
95% betrouwbaarheidsintervallen met daarin 0.6, de waarde die vaak wordt 
waargenomen in eiwit-water verdeling regressies op basis van de Kow. Als 
zwakke interacties dominant zijn, wordt de verdeling van organische 
chemicaliën over verschillende fase bepaald door hydrophobiciteit en 
polariteit, zodat het gerelateerd kan worden aan de Kow van de stof. De helling 
voor FMO was lager (0.2-0.3) waarschijnlijk omdat het reactie mechanisme 
anders is, met een nucleofiele aanval en dus een sterke interactie die niet met 
Kow beschreven kan worden. 
In Hoofdstuk 4 zijn modellen ontwikkeld om beter te begrijpen hoe 
bindingsaffiniteit (1/Km) en maximum reactie snelheid (Vmax) voor substraten 
van ADH, ALDH, FMO en CYP in zoogdieren gerelateerd zijn aan partitie, 
geometrische en electronische eigenschappen van substraten. De verklaarde 
variantie van de modellen varieerde tussen de 20% en 70% en was groter voor 
1/Km dan voor Vmax. De toename van 1/Km met de hydrophobiciteit en de 
grootte van de stof suggereert dat zwakke interacties bijvoorbeeld substraat 
binding via desolvatie, belangrijk zijn. Vmax werd vooral beïnvloed door 
electronische eigenschappen, zoals dipoolmoment en de energie van de 
laagste onbezette moleculaire schil. Dit kan worden verklaard door de aard van 
de katalyse, gekarakteriseerd door de splitsing en vorming van covalente en 
ionbindingen (sterke interacties). 
In Hoofdstuk 5, zijn voorspellende modellen ontwikkeld voor enzymatische 
constanten op basis van theoretische descriptoren. Een genetisch algorithme is 
toegepast om maximaal zes predictoren te selecteren uit een set van meer dan 
2000 potentiële descriptoren, waarbij steeds twee-derde van de xenobiotica in 
elke enzym klasse werden gebruikt. De multiple lineaire modellen zijn daarna 
getoest in een cross-validation met het resterende deel van de stoffen. De 
verklaarde variantie (R2adj) van de modellen was tussen 50% en 80% en het 
voorspellend vermogen (R2ext) tussen 50% en 60%, met uitzondering van die 
voor de Vmax van MFO (R
2
adj < 30%, R
2
ext < 30%). The Vmax waarden van FMO 
waren onafhankelijk van de chemische structuur van het substraat omdat de 
snelheids-beperkende stap van de katalytische cyclus voor de oxidatie ligt. 
Voor de andere enzymen werd Vmax vooral bepaald door functionele groepen 
of fragmenten en door electronische eigenschappen vanwege de sterke en 
specifieke interacties bij de betrokken reacties. De meest relevante 
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predictoren voor 1/Km waren functionele groepen en fragmenten voor 
enzymen die specifieke stoffen metaboliseren (ADH, ALDH en FMO) en grootte 
en vorm eigenschappen voor CYP, waarschijnlijk vanwege de brede substraat 
specificiteit van CYP enzymen. 
Vervolgens werden ook 1/Km and Vmax waarden verzameld voor complete 
levercellen en sub-cellulaire fracties van levercellen en microsomen om 
humane modellen voor in vitro clearence (CLINT, i.e. Vmax/Km) te bouwen. In 
Hoofdstuk 6 zijn multipele lineaire modellen gebouwd en gevalideerd waarbij 
opnieuw maximaal 6 predictoren werden geselecteerd uit een set van 2000 
potentiële descriptoren. Voor het levercel model was de verklaarde variantie 
(R2adj) 67% and het voorspellend vermogen (R
2
ext) 62%. Voor het microsoom 
model was R2adj 50% en R
2
ext 30%. De belangrijkste descriptoren voor beide 
lever testen waren gerelateerd aan de electronische eigenschappen van de 
stof. Functionele groepen van fragmenten bleken bruikbaar om specifieke 
stoffen met een afwijkende reactiesnelheid te identificeren, bijvoorbeeld bij 
slecht afbreekbare polychloorbiphenylen (PCBs) en organische amides. 
Tenslotte zijn in Hoofdstuk 7 de voor- en nadelen van verschillende typen 
descriptoren op verschillende niveau’s van biologische organisatie 
bediscussieerd. Hoewel de modellen voor individuele enzymens bruikbaar 
waren om metabole processen te interpreteren is hun toepassing in de 
risicobeoordeling beperkt. Daarentegen zijn veelbelovende resultaten 
verkregen voor humane levercellen. Bovendien is een algemeen schema 
afgeleid en geëvalueerd voor in vitro – in vivo extrapolatie. De prestaties van 
de modellen zijn echter beperkt door de betrouwbaarheid van de in vitro assay 
systemen. De modellen kunnen verbeterd worden wanneer meer in vitro data 
uit gestandaardiseerde experimenten beschikbaar komen. Daarnaast moet de 
in vitro - in vivo extrapolatie getest worden op een breed spectrum aan 
stoffen. Deze benadering kan geschikt zijn voor een eerste schatting van km in 
een “weight of evidence approach”. 
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